# EDGAR Filing Document

**Accession Number:** 0001892322
**File Stem:** 0001493152-23-007901
**Filing Date:** 2023-3
**Character Count:** 211356
**Document Hash:** 24ee84d139d231223cdbfac36956a587
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-23-007901.hdr.sgml**: 20230316

**ACCESSION NUMBER**: 0001493152-23-007901

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 18

**CONFORMED PERIOD OF REPORT**: 20230313

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230316

**DATE AS OF CHANGE**: 20230316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** HeartCore Enterprises, Inc.
- **CENTRAL INDEX KEY:** 0001892322
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374]
- **IRS NUMBER:** 870913420
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41272
- **FILM NUMBER:** 23738753

**BUSINESS ADDRESS:**
- **STREET 1:** 1-2-33, HIGASHIGOTANDA,
- **STREET 2:** SHINAGAWA-KU
- **CITY:** TOKYO
- **STATE:** M0
- **ZIP:** 1410022
- **BUSINESS PHONE:** 650-695-2583

**MAIL ADDRESS:**
- **STREET 1:** 848 JORDAN AVE. APT G
- **CITY:** LOS ALTOS
- **STATE:** CA
- **ZIP:** 94022

?xml version="1.0" encoding="utf-8"?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of**

**the Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): March 13, 2023**

**<u>HEARTCORE ENTERPRISES, INC.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-41272** | **87-0913420** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (I.R.S. Employer<br> Identification Number) |

---

**<u>1-2-33, Higashigotanda, Shinagawa-ku, Tokyo, Japan</u>**

(Address of principal executive offices)

**<u>+81-3-6409-6966</u>**

(Registrant's telephone number, including area code)

**<u>N/A</u>**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock | HTCR | Nasdaq Capital Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01. Entry into a Material Definitive Agreement.**

*Libera Gaming Operations, Inc. Consulting Agreement*

On March 13, 2023 (the "Libera Effective Date"), HeartCore Enterprises, Inc. (the "Company") entered into a Consulting and Services Agreement (the "Libera Consulting Agreement") by and between the Company and Libera Gaming Operations, Inc., a Japanese corporation ("Libera"). Pursuant to the terms of the Libera Consulting Agreement, the Company agreed to provide Libera certain services, including the following (collectively, the "Libera Services"):

&nbsp;&nbsp;&nbsp;&nbsp;(i) Assistance
 with the selection and negotiation of terms for a law firm, underwriter and auditing firm
 for Libera;

(ii) Assisting
 in the preparation of documentation for internal controls required for an initial public
 offering of de-SPAC or other Libera Fundamental Transaction (as defined in the Libera Consulting
 Agreement) by Libera;

(iii) Providing
 support services to remove problematic accounting accounts upon listing;

(iv) Translation
 of requested documents into English;

(v) Attend
 and, if requested by Libera, lead meetings with Libera's management and employees;

(vi) Provide
 Libera with support services related to Libera's NASDAQ listing;

(vii) Conversion
 of accounting data from Japanese standards to U.S. GAAP;

(viii) Services
 to remove problematic accounting accounts upon listing;

(ix) Support
 for Libera's negotiations with the audit firm;

(x) Assist
 in the preparation of S-1 or F-1 filings;

(xi) Creation
 of English web page; and

(xii) Preparing
 an investor presentation/deck and executive summary of Libera's operations.

In providing the Libera Services, the Company will not render legal advice or perform accounting services, and will not act as an investment advisor or broker/dealer. Pursuant to the terms of the Libera Consulting Agreement, the parties agreed that the Company will not provide the following services, among others: negotiation of the sale of Libera's securities; participation in discussions between Libera and potential investors; assisting in structuring any transactions involving the sale of Libera's securities; pre-screening of potential investors; due diligence activities; nor providing advice relating to valuation of or financial advisability of any investments in Libera.

Pursuant to the terms of the Libera Consulting Agreement, Libera agreed to compensate the Company as follows in return for the provision of the Libera Services during the eight-month term:

&nbsp;&nbsp;&nbsp;&nbsp;(a) $600,000,
 to be paid as follows: (i) $300,000 on the Libera Effective Date; (ii) $150,000 on the three-month
 anniversary of the Libera Effective Date; and (iii) $150,000 on the date that Libera first
 files a Form S-1, Form F-1, Form S-4, Form F-4 or any similar or replacement form with the
 SEC with respect to any transaction which is reasonably expected to result in the Libera
 Trigger Date (as defined in the Libera Warrant); and

&nbsp;&nbsp;&nbsp;&nbsp;(b) Issuance
 by Libera to the Company of a warrant (the "Libera Warrant"), deemed fully earned
 and vested as of the Libera Effective Date, to acquire a number of shares of capital stock
 of Libera, to initially be equal to 3% of the fully diluted share capital of Libera as of
 the Libera Effective Date, subject to adjustment as set forth in the Libera Consulting Agreement
 and the Libera Warrant.

For any services performed by the Company beyond the Libera Term (as hereinafter defined), Libera will compensate the Company for Libera Services at the rate of $150 per hour, based on the hours spent by personnel of the Company.

The term of the Libera Consulting Agreement will continue until eight months after the Libera Effective Date, unless sooner terminated in accordance with the terms of the Libera Consulting Agreement (the "Libera Term"). The Libera Consulting Agreement may be terminated at any time by either party upon notice to the other party.

The foregoing description of the Libera Consulting Agreement is qualified in its entirety by reference to the Libera Consulting Agreement, a copy of which is filed as Exhibit 10.1 hereto and which is incorporated herein by reference.

*Libera Warrant*

As provided in the Libera Consulting Agreement, on the Libera Effective Date, Libera issued the Libera Warrant to the Company. Pursuant to the terms of the Libera Warrant, the Company may, at any time (i) on or after the earlier of the date that either (a) Libera completes its first initial public offering of stock in the U.S. resulting in any class of Libera's stock being listed for trading on any tier of the Nasdaq Stock Market ("Nasdaq"), the New York Stock Exchange ("NYSE") or the NYSE American; (b) Libera consummates a merger or other transaction with a special purpose acquisition company ("SPAC") wherein Libera becomes a subsidiary of the SPAC; or (c) Libera undertakes any other Libera Fundamental Transaction (the "Libera Trigger Date"); and (ii) on or prior to the close of business on the tenth anniversary of the Libera Trigger Date, exercise the Libera Warrant to purchase 2,970 shares of Libera's common stock, which represents 3% of Libera's issued and outstanding common stock as of the Libera Trigger Date, for an exercise price per share of $0.01, subject to adjustment as provided in the Libera Warrant. The number of shares for which the Libera Warrant will be exercisable will be automatically adjusted on the Libera Trigger Date to be 3% of the fully diluted number and class of shares of capital stock of Libera as of the Libera Trigger Date, following completion of the transactions which caused the Libera Trigger Date to be achieved. The Libera Warrant contains a 9.99% equity blocker.

The foregoing description of the Libera Warrant is qualified in its entirety by reference to the Libera Warrant, a copy of which is filed as Exhibit 10.2 hereto and which is incorporated herein by reference.

 *ICheck Co., Ltd. Consulting Agreement*

On March 13, 2023 (the "ICheck Effective Date"), the Company entered into a Consulting and Services Agreement (the "ICheck Consulting Agreement") by and between the Company and ICheck Co., Ltd., a Japanese corporation ("ICheck"). Pursuant to the terms of the ICheck Consulting Agreement, the Company agreed to provide ICheck certain services, including the following (collectively, the "ICheck Services"):

&nbsp;&nbsp;&nbsp;&nbsp;(i) Assistance
 with the selection and negotiation of terms for a law firm, underwriter and auditing firm
 for ICheck;

(ii) Assisting
 in the preparation of documentation for internal controls required for an initial public
 offering of de-SPAC or other ICheck Fundamental Transaction (as defined in the ICheck Consulting
 Agreement) by ICheck;

(iii) Providing
 support services to remove problematic accounting accounts upon listing;

(iv) Translation
 of requested documents into English;

(v) Attend
 and, if requested by ICheck, lead meetings with ICheck's management and employees;

(vi) Provide
 ICheck with support services related to ICheck's NASDAQ listing;

(vii) Conversion
 of accounting data from Japanese standards to U.S. GAAP;

(viii) Services
 to remove problematic accounting accounts upon listing;

(ix) Support
 for ICheck's negotiations with the audit firm;

(x) Assist
 in the preparation of S-1 or F-1 filings;

(xi) Creation
 of English web page; and

(xii) Preparing
 an investor presentation/deck and executive summary of ICheck's operations.

In providing the ICheck Services, the Company will not render legal advice or perform accounting services, and will not act as an investment advisor or broker/dealer. Pursuant to the terms of the ICheck Consulting Agreement, the parties agreed that the Company will not provide the following services, among others: negotiation of the sale of ICheck's securities; participation in discussions between ICheck and potential investors; assisting in structuring any transactions involving the sale of ICheck's securities; pre-screening of potential investors; due diligence activities; nor providing advice relating to valuation of or financial advisability of any investments in ICheck.

Pursuant to the terms of the ICheck Consulting Agreement, ICheck agreed to compensate the Company as follows in return for the provision of the ICheck Services during the nine-month term:

&nbsp;&nbsp;&nbsp;&nbsp;(c) $600,000,
 to be paid as follows: (i) $300,000 on the ICheck Effective Date; (ii) $150,000 on the three-month
 anniversary of the ICheck Effective Date; and (iii) $150,000 on the date that ICheck first
 files a Form S-1, Form F-1, Form S-4, Form F-4 or any similar or replacement form with the
 SEC with respect to any transaction which is reasonably expected to result in the ICheck
 Trigger Date (as defined in the ICheck Warrant); and

&nbsp;&nbsp;&nbsp;&nbsp;(d) Issuance
 by ICheck to the Company of a warrant (the "ICheck Warrant"), deemed fully earned
 and vested as of the ICheck Effective Date, to acquire a number of shares of capital stock
 of ICheck, to initially be equal to 3% of the fully diluted share capital of ICheck as of
 the ICheck Effective Date, subject to adjustment as set forth in the ICheck Consulting Agreement
 and the ICheck Warrant.

For any services performed by the Company beyond the ICheck Term (as hereinafter defined), ICheck will compensate the Company for ICheck Services at the rate of $150 per hour, based on the hours spent by personnel of the Company.

The term of the ICheck Consulting Agreement will continue until nine months after the ICheck Effective Date, unless sooner terminated in accordance with the terms of the ICheck Consulting Agreement (the "ICheck Term"). The ICheck Consulting Agreement may be terminated at any time by either party upon notice to the other party.

The foregoing description of the ICheck Consulting Agreement is qualified in its entirety by reference to the ICheck Consulting Agreement, a copy of which is filed as Exhibit 10.3 hereto and which is incorporated herein by reference.

*ICheck Warrant*

As provided in the ICheck Consulting Agreement, on the ICheck Effective Date, ICheck issued the ICheck Warrant to the Company. Pursuant to the terms of the ICheck Warrant, the Company may, at any time (i) on or after the earlier of the date that either (a) ICheck completes its first initial public offering of stock in the U.S. resulting in any class of ICheck's stock being listed for trading on any tier of Nasdaq, NYSE or the NYSE American; (b) ICheck consummates a merger or other transaction with a SPAC wherein ICheck becomes a subsidiary of the SPAC; or (c) ICheck undertakes any other ICheck Fundamental Transaction (the "ICheck Trigger Date"); and (ii) on or prior to the close of business on the tenth anniversary of the ICheck Trigger Date, exercise the ICheck Warrant to purchase 39,446 shares of ICheck's common stock, which represents 3% of ICheck's issued and outstanding common stock as of the ICheck Trigger Date, for an exercise price per share of $0.01, subject to adjustment as provided in the ICheck Warrant. The number of shares for which the ICheck Warrant will be exercisable will be automatically adjusted on the ICheck Trigger Date to be 3% of the fully diluted number and class of shares of capital stock of ICheck as of the ICheck Trigger Date, following completion of the transactions which caused the ICheck Trigger Date to be achieved. The ICheck Warrant contains a 9.99% equity blocker.

The foregoing description of the ICheck Warrant is qualified in its entirety by reference to the ICheck Warrant, a copy of which is filed as Exhibit 10.4 hereto and which is incorporated herein by reference.

**Item 7.01. Regulation FD Disclosure.**

On March 16, 2023, the Company issued a press release providing an update regarding its Go IPO offering. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

The information included in this Item 7.01, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth under this Item 7.01 shall not be deemed an admission as to the materiality of any information in this Current Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit<br> No.** | **Description** |
| 10.1 | [Consulting and Services Agreement, dated as of March 13, 2023, by and between the registrant and Libera Gaming Operations, Inc.](ex10-1.htm) |
| 10.2 | [Common Stock Purchase Warrant, dated March 13, 2023, issued by Libera Gaming Operations, Inc. to the registrant.](ex10-2.htm) |
| 10.3 | [Consulting and Services Agreement, dated as of March 13, 2023, by and between the registrant and ICheck Co., Ltd.](ex10-3.htm) |
| 10.4 | [Common Stock Purchase Warrant, dated March 13, 2023, issued by ICheck Co., Ltd. to the registrant.](ex10-4.htm) |
| 99.1 | [Press release of the registrant issued on March 16, 2023.](ex99-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **HEARTCORE ENTERPRISES, INC.** | **HEARTCORE ENTERPRISES, INC.** |
| Dated: March 16, 2023 | By: | */s/ Sumitaka Yamamoto* |
|  | Name: | Sumitaka Yamamoto |
|  | Title: | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**<u>CONSULTING AND SERVICES AGREEMENT</u>**

Dated as of March 13, 2022

This Consulting and Services Agreement ("Agreement") is made and entered into as of the date first set forth above (the "Effective Date"), by and between Libera Gaming Operations, Inc., a Japanese corporation (the "Company") and HeartCore Enterprises, Inc., a Delaware corporation ("Consultant"). Each of the Company and Consultant may be referred to herein individually as a "Party" and collectively as the "Parties."

WHEREAS, Consultant is in the business of providing services for management consulting and business advisory; and

WHEREAS, the Company deems it to be in its best interest to retain Consultant to render to the Company such services as may be needed; and

WHEREAS, the Parties agree, after having a complete understanding of the services desired and the services to be provided, that the Company desires to retain Consultant to provide such assistance through its services for the Company, and Consultant is willing to provide such services to the Company;

NOW, THEREFORE, in consideration of the mutual promises set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

Section 1. <u>Engagement</u>. In exchange for the compensation as set forth herein and subject to the other terms and conditions hereinafter set forth, the Company hereby engages Consultant during the Term (as defined below), on a non-exclusive basis, to render the Services set forth in Section 2 as an independent contractor of the Company, and Consultant hereby accepts such engagement.

Section 2. <u>Services</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Subject
 to the terms and conditions and for the Term, Consultant shall provide the Company with the
 following services and such additional services as agreed to by the Company and Consultant
 in writing following the Effective Date (collectively, the "Services"), in each
 case subject to the other limitations below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Assistance
 with the selection and negotiation of terms for a law firm, underwriter and auditing firm
 for the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Assisting
 in the preparation of documentation for internal controls required for an initial public
 offering or de-SPAC transaction or other Fundamental Transaction (as defined in the Warrant,
 as defined below) by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Providing
 support services to remove problematic accounting accounts upon listing support;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Translation
 of requested documents into English;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) Attend
 and, if requested by the Company, lead, meetings of the Company's management and employees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) Provide
 the Company with support services related to the Company's NASDAQ listing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) Conversion
 of accounting data from Japanese standards to US GAAP;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) Support
 for the Company's negotiations with the audit firm;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) Assist
 in the preparation of S-1 or F-1 filings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) Creation
 of English web page; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi) Preparing
 an investor presentation/deck and executive summary of the Company's operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Parties acknowledge and agree that additional details regarding the Services and eventual
 deliverable or end result will be determined by the Parties at the applicable time and will
 in any event be subject to the Company's final agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Notwithstanding
 the definition of the "Services" as set forth above, it is acknowledged and agreed
 by the Company that Consultant carries no professional licenses, and is not rendering legal
 advice or performing accounting services, nor acting as an investment advisor or broker/dealer
 within the meaning of the applicable state and federal securities laws. The Services of Consultant
 shall not be exclusive nor shall Consultant be required to render any specific number of
 hours or assign specific personnel to the Company or its projects, however it is anticipated
 and agreed upon by both Parties that considerable time and resources will be required to
 fulfill the obligations to the Company under this agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Notwithstanding
 the definition of the "Services" as set forth above, the Consultant shall specifically
 not provide any of the following services to the Company: (i) negotiation for the sale of
 any the Company's securities or participation in discussions between the Company and
 the potential investors; (ii) assisting in structuring any transactions involving the sale
 of the Company's securities; (iii) engage in any pre-screening of potential investors
 to determine their eligibility to purchase any securities or engaging in any pre-selling
 efforts for the Company's securities; (iv) discuss details of the nature of the securities
 sold or whether recommendations were made concerning the sale of the securities; (v) engage
 in due diligence activities; (vi) provide advice relating to the valuation of or the financial
 advisability of any investments in the Company; or (vii) handle any funds or securities on
 behalf of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Consultant
 will use its commercially reasonable efforts to provide the Services using the best of its
 professional skills and in a manner consistent with generally accepted standards for the
 performance of such work.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Consultant
 shall devote such of its time and effort necessary to the discharge of its duties hereunder.
The Company acknowledges that Consultant is engaged in other business activities, and that it will continue such activities during the
term of this Agreement. Consultant shall not be restricted from engaging in other business activities during the term of this Agreement.

Section 3. <u>Term; Termination</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 term of this Agreement shall commence on the Effective Date and shall continue for a period
 of eight months thereafter ("Term"), unless sooner terminated in accordance with
 the terms herein. The Term may be renewed upon the mutual written agreement of the Parties
 via an amendment of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This
 Agreement and the Term may be terminated at any time by either Party upon notice to the other
 Party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Upon
 the termination or expiration of the Term, the Parties shall have no further obligations
 hereunder other than those which arose prior to such termination or which are explicitly
 set forth herein as surviving any such termination or expiration.

Section 4. <u>Compensation and Expenses</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) As
 full and complete compensation for Consultant's agreement to perform the services,
 the Company shall compensate Consultant as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) In
 return for the provision of the Services, the Company shall pay to the Consultant the sum
 of $600,000 (the "Services Fee") and shall issue to Consultant a warrant to acquire
 a number of shares of capital stock of the Company, to initially be equal to 3% of the fully
 diluted share capital of the Company as of Effective Date, to be substantially in the form
 as attached hereto as Exhibit A, which warrant may be revised to provide for an issuer other
 than the Company as set forth therein (the "Warrant"), with such number of shares
 subject to the Warrant to be adjusted as set forth therein. The Warrant shall be deemed fully
 earned and vested as of the Effective Date and shall be non-returnable to the Company for
 any reason.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The
 Services Fee shall be paid as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) $300,000
 on the Effective Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) $150,000
 on the three month anniversary of the Effective Date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) $150,000
 on the date that the Company first files a Form S-1, Form F-1, Form S-4, Form F-4 or any
 similar or replacement form with the United States Securities and Exchange Commission with
 respect to any transaction which is reasonably expected to result in the Trigger Date (as
 defined in the Warrant) occurring (any such transaction, the "Transaction").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Notwithstanding
 the prior payment of the Services Fee, in the event that, prior to the expiration of the
 Term, the Company elects to abandon and no longer pursue a Transaction, the
Company shall provide Consultant written notice of such decision, and the Consultant shall thereafter promptly return to the Company
all portions of the Services Fee paid to such time, less any unreimbursed expenses incurred by the Consultant in providing the Services
to such date, and the Term shall be deemed automatically terminated at such time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) In
 the event that the Term is extended beyond the initial eight-month term, the Company shall
 compensate Consultant for the Services at the rate of $150 per hour based on the hours spent
 by personnel of Consultant providing the Services. The Company may set forth limits on the
 number of hours that may be spent on any Services, or other terms and conditions related
 thereto, which may be communicated to Consultant by email or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) During
 the Term of the Agreement the Company will reimburse the Consultant's travel and other
 reasonable expenses related to Consultant's performance under this Agreement, on a
 monthly basis, within 30 days of Consultant's submission to Company of invoices and
 receipts related to said expenses in form as reasonably acceptable to the Company. All expenses
 must be approved in writing by the Company in advance of Consultant incurring said expenses,
 and any expenses not pre-approved in writing by Company shall not be reimbursed and shall
 be Consultant's sole responsibility.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Consultant
 shall be responsible for any and all taxes incurred by or payable by Consultant with respect
 to all compensation or reimbursement of expenses or any other payments made to Consultant
 hereunder. In furtherance thereof, Consultant shall pay to the Company, or make arrangements
 satisfactory to the Company regarding the payment of, all federal, state, local and foreign
 taxes that are required by applicable laws and regulations to be withheld by the Company
 with respect to such amount.

Section 5. <u>No Employee Status</u>. The Parties also acknowledge and agree that Consultant is an independent contractor and is not an employee or agent of Company in its position as a consultant and advisor. As such, Company shall not be liable for any employment tax, withholding tax, social security tax, worker's compensation or any other tax, insurance, expense or liability with respect to any or all compensation, reimbursements and remuneration Consultant may receive hereunder, all of which shall be the sole responsibility of Consultant. Consultant is solely responsible for the reporting and payment of, all pertinent federal, state, or local self-employment or income taxes, licensing fees, or any other taxes or assessments levied by governmental authorities, as well as for all other liabilities or payments related to those services. The Parties also acknowledge and agree that Consultant is not a licensed securities broker or salesperson, and that Consultant will not be participating in, nor compensated for, any unlicensed securities sales activities other than those permitted under any of the exemptions set forth in applicable securities laws.

Section 6. <u>Relationship of the Parties</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Consultant
 is retained by the Company only for the purposes of and to the extent set forth in this Agreement,
 and Consultant' relation to the Company during the period of its engagement hereunder
 shall be that of an independent contractor. Consultant shall not, nor, as applicable, shall
 any of its agents, have employee status with the Company or be entitled to participate in
 any plans, arrangements or distributions by the Company pertaining to or in connection with
 any pension, stock, bonus, profit-sharing or similar benefits as may be available
to the Company's employees. Consultant shall be responsible for the reporting and payment of all income and self-employment taxes
for all compensation paid to Consultant hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This
 Agreement does not create a relationship of principal and agent, joint venture, partnership
 or employment between the Company and Consultant. Consultant' engagement hereunder
 is not a franchise or business opportunity. Neither Party shall be liable for any obligations
 incurred by the other except as expressly provided herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Consultant
 shall not have authority to enter into contracts binding the Company or to create any obligations
 or incur liabilities on behalf of the Company. Consultant shall not act or represent himself,
 directly or by implication, as an agent of the Company with any authority other than as set
 forth expressly in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Any
 person hired by Consultant shall be the employee of Consultant and not of the Company, and
 all compensation, payroll taxes, facilities and related expenses for any such employee shall
 be the sole responsibility of Consultant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Consultant
 acknowledges that it is not an officer, director or agent of Company, it is not, and will
 not, be responsible for any management decisions on behalf of Company, and may not commit
 Company to any action. Company represents that Consultant does not have, through stock ownership
 or otherwise, the power neither to control Company, nor to exercise any dominating influences
 over its management.

Section 7. <u>Representations and Warranties.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Representations and Warranties of the Company</u>. Company represents and warrants hereunder that this Agreement
 and the transactions contemplated hereunder have been duly and validly authorized by all
 requisite corporate action; that Company has the full right, power and capacity to execute,
 deliver and perform its obligations hereunder; and that this Agreement, upon execution and
 delivery of the same by Company, will represent the valid and binding obligation of Company
 enforceable in accordance with its terms, subject to the application of bankruptcy, insolvency,
 reorganization, moratorium or other similar laws affecting the enforcement of creditors'
 rights generally and general principles of equity, regardless of whether enforceability is
 considered in a proceeding at law or in equity (the "Enforceability Exceptions").
 The representations and warranties set forth herein shall survive the termination or expiration
 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Representations and Warranties of Consultant.</u> Consultant represents and warrants hereunder that this
 Agreement and the transactions contemplated hereunder have been duly and validly authorized
 by all requisite action; that Consultant has the full right, power and capacity to execute,
 deliver and perform its obligations hereunder; and that this Agreement, upon execution and
 delivery of the same by Consultant, will represent the valid and binding obligation of Consultant
 enforceable in accordance with its terms, subject to the Enforceability Exceptions. Consultant
 represents and warrants that all personnel or agents of Consultant who perform any activities
 on behalf of the Company hereunder or otherwise are legally authorized and permitted to work
 in the United States and for the benefit of the Company hereunder. The representations and
 warranties set forth herein shall survive the termination
or expiration of this Agreement The representations and warranties set forth herein shall survive the termination or expiration of this
Agreement.

Section 8. <u>Indemnification</u>. In the event either Party is subject to any action, claim or proceeding resulting from the other's gross negligence or intentional breach of this Agreement, the Party at fault agrees to indemnify and hold harmless the other from any such action, claim or proceeding. Indemnification shall include all fees, costs and reasonable attorneys' fees that the indemnified Party may incur. In claiming indemnification hereunder, the indemnified Party shall promptly provide the indemnifying Party written notice of any claim that the indemnified Party reasonably believes falls within the scope of this Agreement. The indemnified Party may, at its expense, assist in the defense if it so chooses, provided that the indemnifying Party shall control such defense, and all negotiations relative to the settlement of any such claim. Any settlement intended to bind the indemnified Party shall not be final without the indemnified Party's written consent. Any liability of a Party and its officers, directors, controlling persons, employees or agents shall not exceed the amount of fees actually paid to Consultant by the Company pursuant this Agreement.

Section 9. <u>Miscellaneous.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Notices</u>.
 All notices under this Agreement shall be in writing. Notices may be served by certified
 or registered mail, postage paid with return receipt requested; by private courier, prepaid;
 by other reliable form of electronic communication; or personally. Mailed notices shall be
 deemed delivered five (5) days after mailing, properly addressed. Couriered notices shall
 be deemed delivered on the date that the courier warrants that delivery will occur. Electronic
 communication notices shall be deemed delivered when receipt is either confirmed by confirming
 transmission equipment or acknowledged by the addressee or its office. Personal delivery
 shall be effective when accomplished. Any Party may change its address by giving notice,
 in writing, stating its new address, to the other Party. Subject to the forgoing, notices
 shall be sent as follows:

If to the Consultant:

HeartCore Enterprises, Inc.

Attn: Sumitaka Yamamoto

848 Jordan Ave. Apt G

Los Altos CA 94022

Email: kanno@heartcore.co.jp

With a copy, which shall not constitute notice, to:

Anthony L.G., PLLC

Attn: John Cacomanolis

625 N. Flagler Drive, Suite 600

West Palm Beach, FL 33401

Email: JCacomanolis@anthonypllc.com

If to the Company, to:

Libera Gaming Operations, Inc.

Attn: Toyotaka Nagamori

6-25-8-202, Nishishinjuku,

Shinjyuku, Tokyo, 160-0023, Japan

Email: toyotaka.nagamori@libera-group.co.jp

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Accuracy of Statements</u>. Each Party represents and warrants that no representation or warranty
 contained in this Agreement, and no statement delivered or information supplied to the other
 Party pursuant hereto, contains an untrue statement of material fact or omits to state a
 material fact necessary in order to make the statements or information contained herein or
 therein not misleading. The representations and warranties made in this Agreement will be
 continued and will remain true and complete in all material respects and will survive the
 execution of the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Entire Agreement</u>. This Agreement sets forth all the promises, covenants, agreements, conditions
 and understandings between the Parties, and supersedes all prior and contemporaneous agreements,
 understandings, inducements or conditions, expressed or implied, oral or written, except
 as herein or therein contained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Survival</u>.
 The provisions of Section 8 and Section 9 of this Agreement, and any additional provisions
 as required to effect any of such Sections, shall survive any termination or expiration hereof,
 and provided that no expiration or termination of this Agreement shall excuse a Party for
 any liability for obligations arising prior to such expiration or termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Binding Effect; Assignment</u>. This Agreement shall be binding upon and shall inure to the benefit
 of the Parties and their respective successors and permitted assigns. No Party shall have
 any power or any right to assign or transfer, in whole or in part, this Agreement, or any
 of its rights or any of its obligations hereunder, including, without limitation, any right
 to pursue any claim for damages pursuant to this Agreement or the transactions contemplated
 herein, or to pursue any claim for any breach or default of this Agreement, or any right
 arising from the purported assignor's due performance of its obligations hereunder,
 without the prior written consent of the other Party and any such purported assignment in
 contravention of the provisions herein shall be null and void and of no force or effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Amendment</u>.
 Subject to the provisions of Section 4(b) the Parties hereby irrevocably agree that no attempted
 amendment, modification, termination, discharge or change (collectively, "Amendment")
 of this Agreement shall be valid and effective, unless the Parties shall unanimously agree
 in writing to such Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>No Waiver</u>. No waiver of any provision of this Agreement shall be effective unless it is
 in writing and signed by the Party against whom it is asserted, and any such written waiver
 shall only be applicable to the specific instance to which it relates and shall not be deemed
 to be a continuing or future waiver. No failure to exercise and no delay in exercising on
 the part of either of the Parties any right, power or privilege under this Agreement shall
 operate as a waiver of it, nor shall any single or partial exercise of any other right, power
 or privilege preclude any other or further exercise of its exercise of any other right, power
 or privilege

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Gender and Use of Singular and Plural</u>. All pronouns shall be deemed to refer to the masculine,
 feminine, neuter, singular or plural, as the identity of the Party or Parties, or their personal
 representatives, successors and assigns may require.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Headings</u>.
 The article and section headings contained in this Agreement are inserted for convenience
 only and shall not affect in any way the meaning or interpretation of the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <u>Governing Law; Etc</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) This
 Agreement, and any and all claims, proceedings or causes of action relating to this Agreement
 or arising from this Agreement or the transactions contemplated herein, including, without
 limitation, tort claims, statutory claims and contract claims, shall be interpreted, construed,
 governed and enforced under and solely in accordance with the substantive and procedural
 laws of the State of Delaware, in each case as in effect from time to time and as the same
 may be amended from time to time, and as applied to agreements performed wholly within the
 State of Delaware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) SUBJECT
 TO Section 9(k), ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT,
 THE OTHER TRANSACTION DOCUMENTS OR THE CONTEMPLATED TRANSACTIONS SHALL BE INSTITUTED SOLELY
 IN THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA OR THE COURTS OF THE STATE OF CALIFORNIA,
 IN EACH CASE LOCATED IN SANTA CLARA COUNTY, CALIFORNIA, AND EACH PARTY IRREVOCABLY SUBMITS
 TO THE PERSONAL JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING. THE PARTIES
 IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY OBJECTION TO THE LAYING OF VENUE OF ANY SUIT, ACTION
 OR ANY PROCEEDING IN SUCH COURTS AND IRREVOCABLY WAIVE AND AGREE NOT TO PLEAD OR CLAIM IN
 ANY SUCH COURT THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN
 BROUGHT IN AN INCONVENIENT FORUM.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) EACH PARTY HERETO
HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY
OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS, THE PERFORMANCE THEREOF OR THE FINANCINGS CONTEMPLATED
THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR
ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK
TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT
BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS
Section 9(j)(iii).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Each
 of the Parties acknowledge that each has been represented in connection with the signing
 of this waiver by independent legal counsel selected by the respective Party and that such
 Party has discussed the legal consequences and import of this waiver with legal counsel.
 Each of the Parties further acknowledge that each has read and understands the meaning of
 this waiver and grants this waiver knowingly, voluntarily, without duress and only after
 consideration of the consequences of this waiver with legal counsel.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <u>Resolution of Disputes</u>. Except as otherwise provided herein, all controversies, disputes or actions
 between the Parties arising out of this Agreement, including their respective Affiliates,
 owners, officers, directors, agents and employees, arising from or relating to this Agreement
 shall on demand of either Party be submitted for arbitration to in accordance with the rules
 and regulations of the American Arbitration Association. The arbitration shall be conducted
 by one arbitrator jointly selected by each Party who is a party to the Dispute, provided,
 however, that if such Parties are unable to agree on the identity of the arbitrator within
 10 Business Days of commencement of efforts to do so, each Party who is a party to the Dispute
 shall select one arbitrator and the arbitrators so selected shall select a final arbitrator,
 and the final arbitrator shall conduct the arbitration alone. The Parties agree that, in
 connection with any such arbitration proceeding, each shall submit or file any claim which
 would constitute a compulsory counterclaim (as defined by Rule 13 of the Federal Rules of
 Civil Procedures) within the same proceeding as the claim to which it relates. Any such claim
 which is not submitted or filed in such proceeding shall be barred. The arbitrator shall
 be instructed to use every reasonable effort to perform its services within seven days of
 request, and, in any case, as soon as practicable. The Parties agree to be bound by the provisions
 of any limitation on the period of time by which claims must be brought under Delaware law
 or any applicable federal law. The arbitrator(s) shall have the right to award the relief
 which he or she deems proper, consistent with the terms of this Agreement, including compensatory
 damages (with interest on unpaid amounts from due date), injunctive relief, specific performance,
 legal damages and costs. The award and decision of the arbitrator(s) shall be conclusive
 and binding on all Parties, and judgment upon the award may be entered in any court of competent
 jurisdiction. Any right to contest the validity or enforceability of this award shall be
 governed exclusively by the United States Arbitration Act. The arbitration shall be conducted
 in Los Altos, California. The provisions of this Section 9(k) shall continue in full force
 and effect subsequent to and notwithstanding the expiration or termination of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <u>Severability; Expenses; Further Assurances</u>. If any term, condition or other provision of this Agreement
 is determined by a court of competent jurisdiction to be invalid, illegal or incapable of
 being enforced by any rule of law or public policy, all other terms, conditions and provisions
 of this Agreement shall nevertheless remain in full force and effect so long as the economic
 or legal substance of the transactions contemplated by this Agreement is not affected in
 any manner materially adverse to any Party. Upon such determination that any term or other
 provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate
 in good faith to modify this Agreement so as to effect the original intent of the
Parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement be consummated
as originally contemplated to the fullest extent possible. Except as otherwise specifically provided in this Agreement, each Party shall
be responsible for the expenses it may incur in connection with the negotiation, preparation, execution, delivery, performance and enforcement
of this Agreement. The Parties shall from time to time do and perform any additional acts and execute and deliver any additional documents
and instruments that may be required by Law or reasonably requested by any Party to establish, maintain or protect its rights and remedies
under, or to effect the intents and purposes of, this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) <u>Specific Performance</u>. Each Party agrees that irreparable damage would occur if any provision of
 this Agreement were not performed in accordance with the terms hereof and that each Party
 shall be entitled to seek specific performance of the terms hereof in addition to any other
 remedy at law or in equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) <u>Attorneys' Fees</u>. If any Party hereto is required to engage in litigation against any other Party,
 either as plaintiff or as defendant, in order to enforce or defend any rights under this
 Agreement, and such litigation results in a final judgment in favor of such Party ("Prevailing
 Party"), then the party or parties against whom said final judgment is obtained shall
 reimburse the Prevailing Party for all direct, indirect or incidental expenses incurred,
 including, but not limited to, all attorneys' fees, court costs and other expenses
 incurred throughout all negotiations, trials or appeals undertaken in order to enforce the
 Prevailing Party's rights hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) <u>Parties in Interest</u>. This Agreement shall be binding upon and inure solely to the benefit of
 each Party, and nothing in this Agreement, express or implied, is intended to confer upon
 any other person or entity any rights or remedies of any nature whatsoever under or by reason
 of this Agreement other than as specifically set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) <u>Execution in Counterparts, Electronic Transmission</u>. This Agreement may be executed in multiple
 counterparts, each of which shall be deemed an original and all of which taken together shall
 be but a single instrument. Counterparts may be delivered via facsimile, electronic mail
 (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000,
 e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall
 be deemed to have been duly and validly delivered and be valid and effective for all purposes.

*[Signatures appear on following page]*

 

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the Effective Date.

---

| | |
|:---|:---|
| HeartCore Enterprises, Inc. | HeartCore Enterprises, Inc. |
| *By:* | */s/ Sumitaka Yamamoto* |
| Name: | Sumitaka Yamamoto |
| Title: | Chief Executive Officer |
| Libera Gaming Operations, Inc. | Libera Gaming Operations, Inc. |
| *By:* | */s/ Toyotaka Nagamori* |
| Name: | Toyotaka Nagamori |
| Title: | Chief Executive Officer |

---

## Exhibit 10.2

**Exhibit 10.2**

**EITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.**

**COMMON STOCK PURCHASE WARRANT**

**Libera Gaming Operations, Inc.**

---

| | |
|:---|:---|
| **Warrant Shares: 2,970, subject to adjustment as set forth herein.** | **Issuance Date: March 13, 2022** |

---

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, HeartCore Enterprises, Inc., a Delaware corporation, or its registered assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Trigger Date (as defined below) and on or prior to the close of business on the tenth anniversary of the Trigger Date (the "Termination Date") but not thereafter, to subscribe for and purchase from Libera Gaming Operations, Inc., a Japanese corporation (the "Company"), the number of shares of capital stock (the "Common Stock") of the Company (as subject to adjustment hereunder, the "Warrant Shares") as set forth above. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2.

Section 1. <u>Definitions; Warrant Shares</u>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Consulting and Services Agreement dated as of the issuance date as set forth above (the "Issuance Date") between the Company and the Holder (the "Consulting Agreement"). The Company and the Holder acknowledge and agree that the number of Warrant Shares as set forth above represent 3% of the issued and outstanding Common Stock as of the Issuance Date, and that such number of Warrant Shares shall be subject to adjustment as set forth herein. In addition, for purposes herein, the following terms shall have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) "Fundamental
 Transaction" means (i) the Company, directly or indirectly, in one or more related
 transactions effecting any merger or consolidation of the Company with or into another Person,
 (ii) the Company, directly or indirectly, effecting any sale, lease, license, assignment,
 transfer, conveyance or other disposition of all or substantially all of its assets in one
 or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
 offer or exchange offer (whether by the Company or another Person) is completed pursuant
 to which holders of Common Stock are permitted to sell, tender or exchange their shares for
 other securities, cash or property and has been accepted by the holders
of 50% or more of the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one or more related transactions
effecting any reclassification, reorganization or recapitalization of the Common Stock or any compulsory share exchange pursuant to which
the Common Stock is effectively converted into or exchanged for other securities, cash or property, or (v) the Company, directly or indirectly,
in one or more related transactions consummating a stock or share purchase agreement or other business combination (including, without
limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person or group of Persons whereby such
other Person or group acquires more than 50% of the outstanding shares of Common Stock (not including any shares of Common Stock held
by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such
stock or share purchase agreement or other business combination), in each of clauses (i) through (v), inclusive, which is not a Restructuring.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) "IPO"
 means any event wherein any class of the Company's stock becomes listed for trading
 on any tier of the NASDAQ Stock Market, the New York Stock Exchange or the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) "SPAC"
 means a special purpose acquisition company whose stock is listed for trading on any tier
 of the NASDAQ Stock Market, the New York Stock Exchange or the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) "Trigger
 Date" means the earlier of the date that either (i) the Company completes its first
 IPO, (ii) the Company consummates a merger or other transaction with a SPAC wherein the Company
 becomes a subsidiary of the SPAC; or (iii) the Company consummates any other Fundamental
 Transaction.

Section 2. <u>Exercise</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Exercise
 of the purchase rights represented by this Warrant may be made, in whole or in part, at any
 time or times on or after Trigger Date and before the Termination Date by delivery to the
 Company (or such other office or agency of the Company as it may designate by notice in writing
 to the registered Holder at the address of the Holder appearing on the books of the Company)
 of a duly executed facsimile copy of the Notice of Exercise Form attached hereto. Within
 two (2) Trading Days (as defined below) following the date of aforesaid exercise, the Holder
 shall deliver the aggregate Exercise Price (if the exercise is pursuant to Section 2(b))
 for the shares specified in the applicable Notice of Exercise by wire transfer or cashier's
 check drawn on a United States bank specified in the applicable Notice of Exercise. Notwithstanding
 anything herein to the contrary (although the Holder may surrender the Warrant to, and receive
 a replacement Warrant from, the Company), the Holder shall not be required to physically
 surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares
 available hereunder and the Warrant has been exercised in full, in which case, the Holder
 shall surrender this Warrant to the Company for cancellation within three (3) Trading Days
 of the date the final Notice of Exercise is delivered to the Company. Partial exercises of
 this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
 hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
 hereunder in an amount equal to the applicable number
of Warrant Shares purchased. The Holder and the Company shall maintain records showing the number of Warrant Shares purchased and the
date of such purchases. The Company shall deliver any objection to any Notice of Exercise Form within two (2) Trading Days of delivery
of such notice. **The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.** For purposes herein, the term "Trading Day"
means any day that shares of Common Stock are listed for trading or quotation on any tier of the NASDAQ Stock Market, the New York Stock
Exchange or the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Exercise Price</u>. The exercise price per share of the Common Stock under this Warrant shall be $0.01,
 subject to adjustment as described herein (as applicable, the "Exercise Price").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Cashless Exercise</u>. In the event that there is no effective registration statement registering
 the Warrant Shares, or no current prospectus available for the resale of the Warrant Shares
 by the Holder, then this Warrant may also be exercised at the Holder's election, in
 whole or in part, at such time by means of a "cashless exercise" in which the
 Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained
 by dividing [(A-B) \* (X)] by (A), where:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) = the Market Price (as defined below) on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a "cashless exercise," as set forth in the applicable Notice of Exercise, where the "Market Price" equals the highest traded price of the Common Stock during the one hundred fifty (150) Trading Days prior to the date of the respective Exercise Notice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) = the Exercise Price of this Warrant, as adjusted hereunder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

Notwithstanding anything herein to the contrary, on the Termination Date, unless the Holder notifies the Company otherwise, if there is no effective registration statement registering the Warrant Shares, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c); provided however, that if the automatic exercise contemplated under this Section shall result in a conflict with the beneficial ownership limitations of Section 2(f), the Termination Date shall be extended so long as necessary to provide for full exercise of the Warrant under this Section 2(c).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Anti-Dilution Adjustments to Exercise Price</u>. If the Company or any Subsidiary (as defined below) thereof,
 as applicable, at any time while this Warrant is outstanding, shall sell or grant any option
 to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or
 announce any offer, sale, grant or any option to purchase
or other disposition) any Common Stock or securities entitling any person or entity (for purposes of clarification, including but
not limited to the Holder pursuant to (i) any other security of the Company issued to Holder on or after the Issuance Date or
(ii) any other agreement entered into between the Company and Holder) to acquire shares of
Common Stock (upon conversion, exercise or otherwise), at an effective price per share less than the then Exercise Price (such lower
price, the "Base Share Price" and such issuances collectively, a "Dilutive Issuance") (if the holder of the
Common Stock or Common Stock Equivalents (as defined below) so issued shall at any time, whether by operation of purchase price
adjustments, elimination of an applicable floor price for any reason in the future (including but not limited to the passage of time
or satisfaction of certain condition(s)), reset provisions, floating conversion, exercise or exchange prices or otherwise, or due to
warrants, options or rights per share which are issued in connection with such issuance, be entitled or potentially entitled to
receive shares of Common Stock at an effective price per share which is less than the Exercise Price at any time while such Common
Stock or Common Stock Equivalents are in existence, such issuance shall be deemed to have occurred for less than the Exercise Price
on such date of the Dilutive Issuance (regardless of whether the Common Stock or Common Stock Equivalents are (i) subsequently
redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually converted or exercised at such Base
Share Price), then the Exercise Price shall be reduced at the option of the Holder and only reduced to equal the Base Share Price.
Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are issued, regardless of whether the Common
Stock or Common Stock Equivalents are (i) subsequently redeemed or retired by the Company after the date of the Dilutive Issuance or
(ii) actually converted or exercised at such Base Share Price by the holder thereof (for the avoidance of doubt, the Holder may
utilize the Base Share Price even if the Company did not actually issue shares of its common stock at the Base Share Price under the
respective Common stock Equivalents). The Company shall notify the Holder in writing, no later than the Trading Day following the
issuance of any Common Stock or Common Stock Equivalents subject to this Section 2(d), indicating therein the applicable issuance
price, or applicable reset price, exchange price, conversion price and other pricing terms (such notice the "Dilutive Issuance
Notice"). For purposes of clarification, whether or not the Company provides a Dilutive Issuance Notice pursuant to this
Section 2(d), upon the occurrence of any Dilutive Issuance, after the date of such Dilutive Issuance the Holder is entitled to
receive a number of Warrant Shares based upon the Base Share Price regardless of whether the Holder accurately refers to the Base
Share Price in the Notice of Exercise. "Common Stock Equivalents" means any securities of the Company or the
Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt,
preferred stock, right, option, warrant or other instrument that is at any time convertible into or exercisable or exchangeable for,
or otherwise entitles the holder thereof to receive, Common Stock. For purposes herein, "Subsidiaries" means any
corporation or other organization, whether incorporated or unincorporated, in which the Company owns, directly or indirectly, any
equity or other ownership interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Mechanics of Exercise</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Delivery of Certificates Upon Exercise</u>. Certificates for shares purchased hereunder shall be transmitted
 by the Company's then-engaged transfer agent
(the "Transfer Agent") to the Holder by crediting the account of the Holder's prime broker with The Depository Trust
Company through its Deposit or Withdrawal at Custodian system (" <u>DWAC</u> ") if the Company is then a participant in such
system and there is an effective registration statement permitting the issuance of the Warrant Shares to, or resale of the Warrant Shares,
by the Holder and otherwise by physical delivery to the address specified by the Holder in the Notice of Exercise by the date that is
two (2) Trading Days after the delivery to the Company of the Notice of Exercise, (such date, the "Warrant Share Delivery Date").
The Warrant Shares shall be deemed to have been issued, and Holder or any other person so designated to be named therein shall be deemed
to have become a holder of record of such shares for all purposes, as of the date the Warrant has been exercised, with payment to the
Company of the Exercise Price and all taxes required to be paid by the Holder, if any, prior to the issuance of such shares, having been
paid. The Company understands that a delay in the delivery of the Warrant Shares after the Warrant Share Delivery Date could result in
economic loss to the Holder. As compensation to the Holder for such loss, the Company agrees to pay (as liquidated damages and not as
a penalty) to the Holder for late issuance of Warrant Shares upon exercise of this Warrant the amount of $1,000.00 per Trading Day. The
Company shall pay any payments incurred under this Section 2(e) in immediately available funds, or shares of Common Stock of the Company,
in the Holder's discretion, upon demand. Furthermore, in addition to any other remedies which may be available to the Holder, in
the event that the Company fails for any reason to effect delivery of the Warrant Shares by the Warrant Share Delivery Date, the Holder
may revoke all or part of the relevant Warrant exercise by delivery of a notice to such effect to the Company, whereupon the Company
and the Holder shall each be restored to their respective positions immediately prior to the exercise of the relevant portion of this
Warrant, except that the liquidated damages described above shall be payable through the date notice of revocation or rescission is given
to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the
 Company shall, at the request of Holder and upon surrender of this Warrant certificate, at
 the time of delivery of the certificate or certificates representing Warrant Shares, deliver
 to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased
 Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
 be identical with this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Rescission Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder a
 certificate or the certificates representing the Warrant Shares by the Warrant Share Delivery
 Date, then the Holder will have the right, at any time prior to issuance of such Warrant
 Shares, to rescind such exercise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) <u>Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Exercise</u>. In addition to any
 other rights available to the Holder, if the Company fails to cause the Transfer Agent to
 transmit to the Holder a certificate
or the certificates representing the Warrant Shares pursuant to an exercise on or before the Warrant Share Delivery Date, and if after
such date the Holder is required by its broker to purchase (in an open market transaction or otherwise), or the Holder's brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a "Buy-In"), then the Company shall (A) pay in cash to the Holder the amount, if
any, by which (x) the Holder's total purchase price (including brokerage commissions, if any) for the shares of Common Stock so
purchased exceeds (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company was required to deliver to
the Holder in connection with the exercise at issue times (2) the price at which the sell order giving rise to such purchase obligation
was executed, and (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares
for which such exercise was not honored (in which case such exercise shall be deemed rescinded) or deliver to the Holder the number of
shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder.
For example, if the Holder purchases Common Stock having a total purchase price of $11,000.00 to cover a Buy-In with respect to an attempted
exercise of shares of Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000.00, under clause (A)
of the immediately preceding sentence the Company shall be required to pay the Holder $1,000.00. The Holder shall provide the Company
written notice indicating the amounts payable to the Holder in respect of the Buy-In and, upon request of the Company, evidence of the
amount of such loss. Nothing herein shall limit Holder's right to pursue any other remedies available to it hereunder, at law or
in equity including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company's
failure to timely deliver certificates representing shares of Common Stock upon exercise of the Warrant as required pursuant to the terms
hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) <u>No Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares
 shall be issued upon the exercise of this Warrant. As to any fraction of a share which the
 Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at
 its election, either pay a cash adjustment in respect of such final fraction in an amount
 equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) <u>Charges, Taxes and Expenses</u>. Issuance of certificates for Warrant Shares shall be made without
 charge to the Holder for any issue or transfer tax or other incidental expense in respect
 of the issuance of such certificate, all of which taxes and expenses shall be paid by the
 Company, and such certificates shall be issued in the name of the Holder or in such name
 or names as may be directed by the Holder; provided, however, that in the event certificates
 for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant
 when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
 duly executed by the Holder and the Company may require, as a condition thereto, the payment
 of a
sum sufficient to reimburse it for any transfer tax incidental thereto. The Company shall pay all Transfer Agent fees required for same-day
processing of any Notice of Exercise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) <u>Closing of Books</u>. The Company will not close its stockholder books or records in any manner which
 prevents the timely exercise of this Warrant, pursuant to the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Holder's Exercise Limitations</u>. From and after the date that the Warrant Shares are of a class
 of equity of the borrower registered under Section 12(g) of the Exchange Act or the Company
 is subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act,
 the Company shall not effect any exercise of this Warrant, and Holder shall not have the
 right to exercise any portion of this Warrant, to the extent that after giving effect to
 such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder
 (together with the Holder's affiliates, and any other Persons acting as a group together
 with the Holder or any of the Holder's affiliates), would beneficially own in excess
 of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing
 sentence, the number of shares of Common Stock beneficially owned by the Holder and its affiliates
 shall include the number of shares of Common Stock issuable upon exercise of this Warrant
 with respect to which such determination is being made, but shall exclude the number of shares
 of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
 portion of this Warrant beneficially owned by the Holder or any of its affiliates and (ii)
 exercise or conversion of the unexercised or nonconverted portion of any other securities
 of the Company (including, without limitation, any other Common Stock Equivalents) subject
 to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
 owned by the Holder or any of its affiliates. Except as set forth in the preceding sentence,
 for purposes of this Section 2(f), beneficial ownership shall be calculated in accordance
 with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
 it being acknowledged by the Holder that the Company is not representing to the Holder that
 such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is
 solely responsible for any schedules required to be filed in accordance therewith. To the
 extent that the limitation contained in this Section 2(f) applies, the determination of whether
 this Warrant is exercisable (in relation to other securities owned by the Holder together
 with any affiliates) and of which portion of this Warrant is exercisable shall be in the
 sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed
 to be the Holder's determination of whether this Warrant is exercisable (in relation
 to other securities owned by the Holder together with any affiliates) and of which portion
 of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
 and the Company shall have no obligation to verify or confirm the accuracy of such determination.
 In addition, a determination as to any group status as contemplated above shall be determined
 in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
 thereunder. For purposes of this Section 2(f), in determining the number of outstanding shares
 of Common Stock, Holder may rely on the number of outstanding shares of Common Stock as reflected
 in (A) the Company's most recent periodic or annual report filed with the Commission,
 as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
 written notice by the Company or the Transfer Agent setting forth the number of shares of
 Common Stock outstanding. Upon the written or oral
request of Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common
Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the
conversion or exercise of securities of the Company, including this Warrant, by the Holder or its affiliates since the date as of which
such number of outstanding shares of Common Stock was reported. The "Beneficial Ownership Limitation" shall be 9.99% of the
number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon
exercise of this Warrant. The Holder may decrease the Beneficial Ownership Limitation at any time and the Holder, upon not less than
sixty-one (61) days' prior notice to the Company, may increase or waive the Beneficial Ownership Limitation provisions of this
Section 2(f), provided that any such increase or waiver will not be effective until the 61<sup>st</sup> day after such notice is delivered
to the Company. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict conformity with
the terms of this Section 2(f) to correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to
such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

Section 3. <u>Certain Adjustments and Revisions to Warrant</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Fundamental Transaction</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Transaction</u>.
 If, at any time while this Warrant is outstanding, the Company consummates any Fundamental
 Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the
 right to receive, for each Warrant Share that would have been issuable upon such exercise
 immediately prior to the occurrence of such Fundamental Transaction, at the option of the
 Holder, the number of shares of common stock of the successor or acquiring corporation (the
 "Successor Entity"), of the Company, if it is the surviving corporation, and
 any additional consideration (the "Alternate Consideration") receivable as a
 result of such Fundamental Transaction by a holder of the number of shares of Common Stock
 for which this Warrant is exercisable immediately prior to such Fundamental Transaction,
 and any references herein to the "Company", whether standing alone or as a part
 of any other defined term, shall be deemed a reference to the successor or acquiring corporation
 in the Fundamental Transaction, or the Company if it is the surviving corporation, and this
 Warrant shall be so exercisable with respect to the Successor Entity or the Company, as applicable.
 For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
 adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
 issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
 Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
 manner reflecting the relative value of any different components of the Alternate Consideration.
 If holders of Common Stock are given any choice as to the securities, cash or property to
 be received in a Fundamental Transaction, then the Holder shall be given the same choice
 as to the Alternate
Consideration it receives upon any exercise of this Warrant following such Fundamental Transaction. If so requested by the Company, the
Successor Entity or the Holder, each of the Company, the Successor Entity and the Holder shall reasonably cooperate to execute and deliver
such agreements and documents as required to effect the intent of the provisions of this Section 3(a) and the other provisions herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Holder Election</u>. In the event that a Fundamental Transaction occurs prior to the full exercise
 of this Warrant, the Holder, in its sole discretion and as evidenced by written notice to
 the Company and the Successor Entity, if applicable, at any time shall have the right to
 elect to cause the Company and the Successor Entity, if applicable, to issue to Holder a
 new warrant of the Company or the Successor Entity (the "Fundamental Transaction Replacement
 Warrant"), which Fundamental Transaction Replacement Warrant shall be issued within
 three business days of such election by Holder, and shall reflect the terms and conditions
 herein following the effects of this Section 3(a), and the other provisions herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Terms of Replacement Warrant</u>. The Fundamental Transaction Replacement Warrant shall be substantially
 in the form of this Warrant (other than the last sentence of Section 5(e) shall be omitted,
 and such additional changes as reasonably required to reflect any Successor Entity as the
 issuer shall be made), and shall provide for the acquisition of the stock of the Company
 and the Successor Entity, as applicable, and will be for a number of shares of the Company
 and the Successor Entity comprising the number of shares of the Company and the Successor
 Entity into which 3% of the shares of the Company as of the Issuance Date as set forth above
 were converted or exchanged in the Fundamental Transaction, less any proportion of this Warrant
 which has been exercised as of the time of the issuance of the Fundamental Transaction Replacement
 Warrant. By way of example and not limitation, in the event that this Warrant was initially
 exercisable for 1,000 shares of the Company and the Company had 100,000 shares outstanding,
 and assuming no portion of this Warrant had been exercised, if all 100,000 shares of the
 Company were converted or exchanged in a Fundamental Transaction for 1,000,000 shares of
 the Successor Entity, the Fundamental Transaction Replacement Warrant would be exercisable
 for 10,000 shares of the Successor Entity. The Fundamental Transaction Replacement Warrant
 shall be governed by the laws of the jurisdiction of organization of the Company or the Successor
 Entity, as applicable. Upon any issuance of the Fundamental Transaction Replacement Warrant,
 this Warrant shall thereafter be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Restructuring</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>New Entity</u>. In addition to the other provisions herein, the Company and the Holder acknowledge
 and agree that, in connection with preparations for a Trigger Event, it is expected that
 the Company may create a new corporation in the United States, which is expected to be in
 the State of Delaware ("Newco"), to undertake the Trigger Event, and in which
 event the Company is
expected to be acquired by, or merge with, Newco or a subsidiary of Newco, such that Newco will be the entity that completes the Trigger
Event (the "Restructuring").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Holder Election</u>. In the event that the Restructuring is completed prior to the full exercise
 of this Warrant, the Holder, in its sole discretion and as evidenced by written notice to
 the Company at any time prior to or following the completion of the Restructuring, shall
 have the right to elect to cause the Company and Newco to issue to Holder a new warrant of
 Newco to replace this Warrant (the "Restructuring Replacement Warrant"), which
 Restructuring Replacement Warrant shall be issued within three business days of such election
 by Holder, and shall reflect the terms and conditions herein following the effects of this
 Section 3(b), and the other provisions herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Terms of Restructuring Replacement Warrant</u>. The Restructuring Replacement Warrant shall be
 substantially in the form of this Warrant (other than the last sentence of Section 5(e) shall
 be omitted, and such additional changes as reasonably required to reflect the Newco as the
 issuer shall be made), and shall provide for the acquisition of the stock of Newco, and will
 be for a number of shares of Newco comprising the number of shares of Newco into which 3%
 of the shares of the Company as of the Issuance Date as set forth above were converted or
 exchanged in the Restructuring, less any proportion of this Warrant which has been exercised
 as of the time of the issuance of the Restructuring Replacement Warrant. By way of example
 and not limitation, in the event that this Warrant was initially exercisable for 1,000 shares
 of the Company and the Company had 100,000 shares outstanding, and assuming no portion of
 this Warrant had been exercised, if all 100,000 shares of the Company were converted or exchanged
 in an Restructuring for 1,000,000 shares of Newco, the Restructuring Replacement Warrant
 would be exercisable for 10,000 shares of Newco. The Restructuring Replacement Warrant shall
 be governed by the laws of the jurisdiction of organization of Newco. Upon any issuance of
 the Restructuring Replacement Warrant, this Warrant shall thereafter be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Adjustment of Warrant Shares</u>. The number of Warrant Shares for which this Warrant shall be exercisable
 shall be automatically adjusted on the Trigger Date to be 3% of the fully diluted number
 and class of shares of capital stock of the Company or any Successor Entity, as applicable,
 as of the Trigger Date, following completion of the transactions which caused the Trigger
 Date to be achieved.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding:
 (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of
 its Common Stock or any other equity or equity equivalent securities payable in shares of
 Common Stock; (ii) subdivides outstanding shares of Common Stock into a larger number of
 shares; (iii) combines (including by way of reverse stock split) outstanding shares of Common
 Stock into a smaller number of shares; or (iv) issues by reclassification of shares of the
 Common Stock any shares of capital stock of the
Company, then in each case the Exercise Price shall be multiplied by a fraction of which the numerator shall be the number of shares
of Common Stock (excluding treasury shares, if any) outstanding immediately before such event and of which the denominator shall be the
number of shares of Common Stock outstanding immediately after such event, and the number of shares issuable upon exercise of this Warrant
shall be proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain unchanged. Any adjustment made
pursuant to this Section 3(a) shall become effective immediately after the record date for the determination of stockholders entitled
to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision,
combination or re-classification.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Non-Circumvention</u>.
 The intent of the provisions of this Section 3 is that the Holder will be entitled to acquire
 shares of stock in the entity in which or through which the Company consummates any Trigger
 Event, whether following a Restructuring or not, and whether being the Company, Newco or
 any Successor Entity, and the Company shall not undertake any actions or fail to take any
 actions which would reasonably be expected to frustrate such intent, and shall take such
 actions as reasonably required to effect such intent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Voluntary Reduction</u>. The Company may unilaterally reduce the Exercise Price at any time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>Calculations</u>.
 All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th
 of a share, as the case may be. For purposes of this Section 3, the number of shares of Common
 Stock deemed to be issued and outstanding as of a given date shall be the sum of the number
 of shares of Common Stock (excluding treasury shares, if any) issued and outstanding. For
 the avoidance of doubt, the adjustments to the number of Warrant Shares and to the Exercise
 Price as set forth in each of Section 2(d), Section 3(a), Section 3(b), Section 3(c) and
 Section 3(d), and any other adjustment or modification provisions herein, shall each operate
 independently of each other, and cumulatively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Notice to Holder</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Adjustments</u>.
 Whenever the Exercise Price or the number of Warrant Shares is adjusted pursuant to any provision
 in this Warrant, or in the event of any Fundamental Transaction or Restructuring, the Company
 shall promptly mail to the Holder a notice setting forth the Exercise Price and the number
 of Warrant Shares after such adjustment and setting forth a brief statement of the facts
 requiring such adjustment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common Stock;
(B) the Company shall declare a special nonrecurring cash dividend on, or a redemption of, the Common Stock; (C) the Company shall authorize
the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital stock of any class
or of any rights; (D) the approval of any stockholders of the Company shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all of
the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities; or (E) the Company
shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then, in each case,
to the extent that such information constitutes material non-public information (as determined in good faith by the Company) the Company
shall follow the procedure described the Consulting Agreement and shall deliver to the Holder at its last address as it shall appear
upon the Warrant Register of the Company, at least twenty (20) calendar days prior to the applicable record or effective date hereinafter
specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution, redemption,
rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled
to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure to
mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required to be
specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information
regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the SEC pursuant to a Current
Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice
to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

Section 4. <u>Transfer of Warrant</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Transferability</u>.
 Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder
 (including, without limitation, any registration rights) are transferable, in whole or in
 part, upon surrender of this Warrant at the principal office of the Company or its designated
 agent, together with a written assignment of this Warrant substantially in the form attached
 hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
 transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
 such payment, the Company shall execute and deliver a new Warrant or Warrants in the name
 of the assignee or assignees, as applicable, and in the denomination or denominations specified
 in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
 the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.
 The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder
 for the purchase of Warrant Shares without having a new Warrant issued.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>New Warrants</u>. Subject to compliance with all applicable securities laws, this Warrant may
be divided or combined with other Warrants upon presentation hereof at the aforesaid office of the Company, together with a written notice
specifying the names and denominations in which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject
to compliance with Section 4(a), as to any transfer which may be involved in such division or combination, the Company shall execute
and deliver a new Warrant or Warrants in exchange for the Warrant or Warrants to be divided or combined in accordance with such notice.
All Warrants issued on transfers or exchanges shall be dated the initial issuance date of this Warrant and shall be identical with this
Warrant except as to the number of Warrant Shares issuable pursuant thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the
 Company for that purpose (the "Warrant Register"), in the name of the record
 Holder hereof from time to time. The Company may deem and treat the registered Holder of
 this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
 to the Holder, and for all other purposes, absent actual notice to the contrary.

Section 5. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>No Rights as Stockholder Until Exercise</u>. This Warrant does not entitle the Holder to any
 voting rights, dividends or other rights as a stockholder of the Company prior to the exercise
 hereof as set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt
 by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction
 or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and
 in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to
 it (which shall not include the posting of any bond), and upon surrender and cancellation
 of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new
 Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of
 such Warrant or stock certificate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or
 the expiration of any right required or granted herein shall not be a Trading Day, then,
 such action may be taken or such right may be exercised on the next succeeding Trading Day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Authorized Shares</u>. The Company covenants that, during the period the Warrant is outstanding, it
 will reserve from its authorized and unissued Common Stock a sufficient number of shares
 to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
 under this Warrant, which number shall be at least 300% of the number of Warrant Shares to
 be issued upon exercise of this Warrant. The Company further covenants that its issuance
 of this Warrant shall constitute full authority to its officers who are charged with the
 duty of executing stock certificates to execute and issue the necessary certificates for
 the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
 will take all such reasonable action as may be necessary to assure that such Warrant Shares
 may be issued as provided herein without violation of any applicable law or regulation, or
 of any requirements of the trading market upon which the Common Stock may be listed. The
 Company covenants that all Warrant
Shares which may be issued upon the exercise of the purchase rights represented by this Warrant will, upon exercise of the purchase
rights represented by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized, validly issued,

(other than taxes in respect of any transfer occurring contemporaneously with such issue). Except and to the extent as waived or
consented to by the Holder, the Company shall not by any action, including, without limitation, amending its certificate of
incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or
any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms of this Warrant, but will at
all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or
appropriate to protect the rights of Holder as set forth in this Warrant against impairment. Without limiting the generality of the
foregoing, the Company will (i) not increase the par value of any Warrant Shares above the amount payable therefor upon such
exercise immediately prior to such increase in par value; (ii) take all such action as may be necessary or appropriate in order that
the Company may validly and legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant; and (iii)
use commercially reasonable efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having
jurisdiction thereof, as may be, necessary to enable the Company to perform its obligations under this Warrant. Before taking any
action which would result in an adjustment in the number of Warrant Shares for which this Warrant is exercisable or in the Exercise
Price, the Company shall obtain all such authorizations or exemptions thereof, or consents thereto, as may be necessary from any
public regulatory body or bodies having jurisdiction thereof. Failure to maintain sufficient shares for exercise of the Warrant,
shall constitute an Event of Default under the Consulting Agreement and Holder shall be able to rely on any applicable default
remedies thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Governing Law and Jurisdiction</u>. This Warrant, and any and all claims, proceedings or causes of
 action relating to this Warrant or arising from this Warrant or the transactions contemplated
 herein, including, without limitation, tort claims, statutory claims and contract claims,
 shall be interpreted, construed, governed and enforced under and solely in accordance with
 the substantive and procedural laws of the State of Delaware, in each case as in effect from
 time to time and as the same may be amended from time to time, and as applied to agreements
 performed wholly within the State of Delaware. All questions concerning jurisdiction, venue
 and the construction, validity, enforcement and interpretation of this Warrant shall be determined
 in accordance with the provisions of the Consulting Agreement. Notwithstanding the foregoing,
 to the extent that the laws of Japan are required to apply hereto in order to give effect
 hereto, the laws of Japan shall so apply.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Restrictions</u>.
 The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant,
 if not registered, will have restrictions upon resale imposed by state and federal securities
 laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>Non-waiver and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder
 on the part of Holder shall operate as a waiver of such right or otherwise prejudice the
 Holder's rights, powers or remedies. Without limiting any other provision of
this Warrant or the Consulting Agreement, if the Company fails to comply with any provision of this Warrant, which results in any material
damages to the Holder, the Company shall pay to the Holder such amounts as shall be sufficient to cover any costs and expenses including,
but not limited to, reasonable attorneys' fees, including those of appellate proceedings, incurred by the Holder in collecting
any amounts due pursuant hereto or in otherwise enforcing any of its rights, powers or remedies hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Notices</u>.
 Any notice, request or other document required or permitted to be given or delivered to the
 Holder by the Company shall be delivered in accordance with the notice provisions of the
 Consulting Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder
 to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights
 or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
 price of any Common Stock or as a stockholder of the Company, whether such liability is asserted
 by the Company or by creditors of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <u>Remedies</u>.
 The Holder, in addition to being entitled to exercise all rights granted by law, including
 recovery of damages, will be entitled to specific performance of its rights under this Warrant.
 The Company agrees that monetary damages would not be adequate compensation for any loss
 incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
 to waive and not to assert the defense in any action for specific performance that a remedy
 at law would be adequate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations
 evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted
 assigns of the Company and the successors and permitted assigns of Holder. The provisions
 of this Warrant are intended to be for the benefit of any Holder from time to time of this
 Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <u>Amendment</u>.
 Other than as specifically set forth herein, this Warrant may be modified or amended or the
 provisions hereof waived only with the written consent of the Company and the Holder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) <u>Severability</u>.
 Wherever possible, each provision of this Warrant shall be interpreted in such manner as
 to be effective and valid under applicable law, but if any provision of this Warrant shall
 be prohibited by or invalid under applicable law, such provision shall be ineffective to
 the extent of such prohibition or invalidity, without invalidating the remainder of such
 provisions or the remaining provisions of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) <u>Headings</u>.
 The headings used in this Warrant are for the convenience of reference only and shall not,
 for any purpose, be deemed a part of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) <u>Execution in Counterparts, Electronic Transmission</u>. This Warrant may be executed in multiple counterparts,
 each of which shall be deemed an original and all of which taken together shall be but a
 single instrument. Counterparts may be delivered via facsimile, electronic mail (including
 pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.,
 www.docusign.com) or other transmission method and any
counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.

*[Signatures appear on following page]*

 

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of Issuance Date.

---

| | |
|:---|:---|
| Libera Gaming Operations, Inc. | Libera Gaming Operations, Inc. |
| *By:* | */s/ Toyotaka Nagamori* |
| Name: | Toyotaka Nagamori |
| Title: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| *Agreed and accepted:* | *Agreed and accepted:* |
| HeartCore Enterprises, Inc. | HeartCore Enterprises, Inc. |
| *By:* | */s/ Sumitaka Yamamoto* |
| Name: | Sumitaka Yamamoto |
| Title: | Chief Executive Officer |

---

**NOTICE OF EXERCISE**

TO: *[Issuer Name]*

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The undersigned hereby elects to purchase<u> </u>Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2) Payment shall take the form of lawful money of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:

___________________________________

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) After giving effect to this Notice of Exercise, the undersigned will not have exceeded the Beneficial Ownership Limitation.

The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:

__________________________________________

__________________________________________

__________________________________________

__________________________________________

Name of Investing Entity:

__________________________________________

*Signature of Authorized Signatory of Investing Entity*:

__________________________________________

Name: <br> Title: <br> Date:

**ASSIGNMENT FORM**

(To assign the foregoing warrant, execute this form and supply required information. Do not use this form to exercise the warrant.)

[*<u>Issuer name]</u>*

 

FOR VALUE RECEIVED, [ ___________ ] all of or [ ___________ ]shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to __________________________________________ whose address is ______________________________________________________________________.

Dated: _________________________________________, _______________

---

| |
|:---|
| Holder's Signature: |
| Holder's Address: |

---

Signed in the presence of:

_________________________________

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

## Exhibit 10.3

**Exhibit 10.3**

**<u>CONSULTING AND SERVICES AGREEMENT</u>**

Dated as of March 13, 2023

This Consulting and Services Agreement ("Agreement") is made and entered into as of the date first set forth above (the "Effective Date"), by and between ICheck Co., Ltd., a Japanese corporation (the "Company") and HeartCore Enterprises, Inc., a Delaware corporation ("Consultant"). Each of the Company and Consultant may be referred to herein individually as a "Party" and collectively as the "Parties."

WHEREAS, Consultant is in the business of providing services for management consulting and business advisory; and

WHEREAS, the Company deems it to be in its best interest to retain Consultant to render to the Company such services as may be needed; and

WHEREAS, the Parties agree, after having a complete understanding of the services desired and the services to be provided, that the Company desires to retain Consultant to provide such assistance through its services for the Company, and Consultant is willing to provide such services to the Company;

NOW, THEREFORE, in consideration of the mutual promises set forth herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

Section 1. <u>Engagement</u>. In exchange for the compensation as set forth herein and subject to the other terms and conditions hereinafter set forth, the Company hereby engages Consultant during the Term (as defined below), on a non-exclusive basis, to render the Services set forth in Section 2 as an independent contractor of the Company, and Consultant hereby accepts such engagement.

Section 2. <u>Services</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Subject
 to the terms and conditions and for the Term, Consultant shall provide the Company with the
 following services and such additional services as agreed to by the Company and Consultant
 in writing following the Effective Date (collectively, the "Services"), in each
 case subject to the other limitations below:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Assistance
 with the selection and negotiation of terms for a law firm, underwriter and auditing firm
 for the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Assisting
 in the preparation of documentation for internal controls required for an initial public
 offering or de-SPAC transaction or other Fundamental Transaction (as defined in the Warrant,
 as defined below) by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) Providing
 support services to remove problematic accounting accounts upon listing support;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Translation
 of requested documents into English;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) Attend
 and, if requested by the Company, lead, meetings of the Company's management and employees;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) Provide
 the Company with support services related to the Company's NASDAQ listing;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) Conversion
 of accounting data from Japanese standards to US GAAP;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(viii) Support
 for the Company's negotiations with the audit firm;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ix) Assist
 in the preparation of S-1 or F-1 filings;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(x) Creation
 of English web page; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(xi) Preparing
 an investor presentation/deck and executive summary of the Company's operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 Parties acknowledge and agree that additional details regarding the Services and eventual
 deliverable or end result will be determined by the Parties at the applicable time and will
 in any event be subject to the Company's final agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Notwithstanding
 the definition of the "Services" as set forth above, it is acknowledged and agreed
 by the Company that Consultant carries no professional licenses, and is not rendering legal
 advice or performing accounting services, nor acting as an investment advisor or broker/dealer
 within the meaning of the applicable state and federal securities laws. The Services of Consultant
 shall not be exclusive nor shall Consultant be required to render any specific number of
 hours or assign specific personnel to the Company or its projects, however it is anticipated
 and agreed upon by both Parties that considerable time and resources will be required to
 fulfill the obligations to the Company under this agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Notwithstanding
 the definition of the "Services" as set forth above, the Consultant shall specifically
 not provide any of the following services to the Company: (i) negotiation for the sale of
 any the Company's securities or participation in discussions between the Company and
 the potential investors; (ii) assisting in structuring any transactions involving the sale
 of the Company's securities; (iii) engage in any pre-screening of potential investors
 to determine their eligibility to purchase any securities or engaging in any pre-selling
 efforts for the Company's securities; (iv) discuss details of the nature of the securities
 sold or whether recommendations were made concerning the sale of the securities; (v) engage
 in due diligence activities; (vi) provide advice relating to the valuation of or the financial
 advisability of any investments in the Company; or (vii) handle any funds or securities on
 behalf of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Consultant
 will use its commercially reasonable efforts to provide the Services using the best of its
 professional skills and in a manner consistent with generally accepted standards for the
 performance of such work.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Consultant
 shall devote such of its time and effort necessary to the discharge of its duties hereunder.
 The Company acknowledges that Consultant is engaged in other business activities, and that
 it will continue such activities during the term of this Agreement. Consultant shall not
 be restricted from engaging in other business activities during the term of this Agreement.

Section 3. <u>Term; Termination</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 term of this Agreement shall commence on the Effective Date and shall continue for a period
 of nine months thereafter ("Term"), unless sooner terminated in accordance with
 the terms herein. The Term may be renewed upon the mutual written agreement of the Parties
 via an amendment of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This
 Agreement and the Term may be terminated at any time by either Party upon notice to the other
 Party.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Upon
 the termination or expiration of the Term, the Parties shall have no further obligations
 hereunder other than those which arose prior to such termination or which are explicitly
 set forth herein as surviving any such termination or expiration.

Section 4. <u>Compensation and Expenses</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) As
 full and complete compensation for Consultant's agreement to perform the services,
 the Company shall compensate Consultant as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) In
 return for the provision of the Services, the Company shall pay to the Consultant the sum
 of $600,000 (the "Services Fee") and shall issue to Consultant a warrant to acquire
 a number of shares of capital stock of the Company, to initially be equal to 3% of the fully
 diluted share capital of the Company as of Effective Date, to be substantially in the form
 as attached hereto as Exhibit A, which warrant may be revised to provide for an issuer other
 than the Company as set forth therein (the "Warrant"), with such number of shares
 subject to the Warrant to be adjusted as set forth therein. The Warrant shall be deemed fully
 earned and vested as of the Effective Date and shall be non-returnable to the Company for
 any reason.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) The
 Services Fee shall be paid as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) $300,000
 on the Effective Date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) $150,000
 on the three month anniversary of the Effective Date; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) $150,000
 on the date that the Company first files a Form S-1, Form F-1, Form S-4, Form F-4 or any
 similar or replacement form with the United States Securities and Exchange Commission with
 respect to any transaction which is reasonably expected to result in the Trigger Date (as
 defined in the Warrant) occurring (any such transaction, the "Transaction").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Notwithstanding
 the prior payment of the Services Fee, in the event that, prior to the expiration of the
 Term, the Company elects to abandon and no longer pursue a Transaction, the Company shall
 provide Consultant written notice of such decision, and the Consultant shall thereafter promptly
 return to the Company all portions of the Services Fee paid to such time, less any unreimbursed
 expenses incurred by the Consultant in providing the Services to such date, and the Term
 shall be deemed automatically terminated at such time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) In
 the event that the Term is extended beyond the initial nine-month term, the Company shall
 compensate Consultant for the Services at the rate of $150 per hour based on the hours spent
 by personnel of Consultant providing the Services. The Company may set forth limits on the
 number of hours that may be spent on any Services, or other terms and conditions related
 thereto, which may be communicated to Consultant by email or otherwise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) During
 the Term of the Agreement the Company will reimburse the Consultant's travel and other
 reasonable expenses related to Consultant's performance under this Agreement, on a
 monthly basis, within 30 days of Consultant's submission to Company of invoices and
 receipts related to said expenses in form as reasonably acceptable to the Company. All expenses
 must be approved in writing by the Company in advance of Consultant incurring said expenses,
 and any expenses not pre-approved in writing by Company shall not be reimbursed and shall
 be Consultant's sole responsibility.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Consultant
 shall be responsible for any and all taxes incurred by or payable by Consultant with respect
 to all compensation or reimbursement of expenses or any other payments made to Consultant
 hereunder. In furtherance thereof, Consultant shall pay to the Company, or make arrangements
 satisfactory to the Company regarding the payment of, all federal, state, local and foreign
 taxes that are required by applicable laws and regulations to be withheld by the Company
 with respect to such amount.

Section 5. <u>No Employee Status</u>. The Parties also acknowledge and agree that Consultant is an independent contractor and is not an employee or agent of Company in its position as a consultant and advisor. As such, Company shall not be liable for any employment tax, withholding tax, social security tax, worker's compensation or any other tax, insurance, expense or liability with respect to any or all compensation, reimbursements and remuneration Consultant may receive hereunder, all of which shall be the sole responsibility of Consultant. Consultant is solely responsible for the reporting and payment of, all pertinent federal, state, or local self-employment or income taxes, licensing fees, or any other taxes or assessments levied by governmental authorities, as well as for all other liabilities or payments related to those services. The Parties also acknowledge and agree that Consultant is not a licensed securities broker or salesperson, and that Consultant will not be participating in, nor compensated for, any unlicensed securities sales activities other than those permitted under any of the exemptions set forth in applicable securities laws.

Section 6. <u>Relationship of the Parties</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Consultant
 is retained by the Company only for the purposes of and to the extent set forth in this Agreement,
 and Consultant' relation to the Company during the period of its engagement hereunder
 shall be that of an independent contractor. Consultant shall not, nor, as applicable, shall
 any of its agents, have employee status with the Company or be entitled to participate in
 any plans, arrangements or distributions by the Company pertaining to or in connection with
 any pension, stock, bonus, profit-sharing or similar benefits as may be available to the
 Company's employees. Consultant shall be responsible for the reporting and payment
 of all income and self-employment taxes for all compensation paid to Consultant hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) This
 Agreement does not create a relationship of principal and agent, joint venture, partnership
 or employment between the Company and Consultant. Consultant' engagement hereunder
 is not a franchise or business opportunity. Neither Party shall be liable for any obligations
 incurred by the other except as expressly provided herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Consultant
 shall not have authority to enter into contracts binding the Company or to create any obligations
 or incur liabilities on behalf of the Company. Consultant shall not act or represent himself,
 directly or by implication, as an agent of the Company with any authority other than as set
 forth expressly in this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Any
 person hired by Consultant shall be the employee of Consultant and not of the Company, and
 all compensation, payroll taxes, facilities and related expenses for any such employee shall
 be the sole responsibility of Consultant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Consultant
 acknowledges that it is not an officer, director or agent of Company, it is not, and will
 not, be responsible for any management decisions on behalf of Company, and may not commit
 Company to any action. Company represents that Consultant does not have, through stock ownership
 or otherwise, the power neither to control Company, nor to exercise any dominating influences
 over its management.

Section 7. <u>Representations and Warranties.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Representations and Warranties of the Company</u>. Company represents and warrants hereunder that this Agreement
 and the transactions contemplated hereunder have been duly and validly authorized by all
 requisite corporate action; that Company has the full right, power and capacity to execute,
 deliver and perform its obligations hereunder; and that this Agreement, upon execution and
 delivery of the same by Company, will represent the valid and binding obligation of Company
 enforceable in accordance with its terms, subject to the application of bankruptcy, insolvency,
 reorganization, moratorium or other similar laws affecting the enforcement of creditors'
 rights generally and general principles of equity, regardless of whether enforceability is
 considered in a proceeding at law or in equity (the "Enforceability Exceptions").
 The representations and warranties set forth herein shall survive the termination or expiration
 of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Representations and Warranties of Consultant.</u> Consultant represents and warrants hereunder that this
 Agreement and the transactions contemplated hereunder have been duly and validly authorized
 by all requisite action; that Consultant has the full right, power and capacity to execute,
 deliver and perform its obligations hereunder; and that this Agreement, upon execution and
 delivery of the same by Consultant, will represent the valid and binding obligation of Consultant
 enforceable in accordance with its terms, subject to the Enforceability Exceptions. Consultant
 represents and warrants that all personnel or agents of Consultant who perform any activities
 on behalf of the Company hereunder or otherwise are legally authorized and permitted to work
 in the United States and for the benefit of the Company hereunder. The representations and
 warranties set forth herein shall survive the termination or expiration of this Agreement
 The representations and warranties set forth herein shall survive the termination or expiration
 of this Agreement.

Section 8. <u>Indemnification</u>. In the event either Party is subject to any action, claim or proceeding resulting from the other's gross negligence or intentional breach of this Agreement, the Party at fault agrees to indemnify and hold harmless the other from any such action, claim or proceeding. Indemnification shall include all fees, costs and reasonable attorneys' fees that the indemnified Party may incur. In claiming indemnification hereunder, the indemnified Party shall promptly provide the indemnifying Party written notice of any claim that the indemnified Party reasonably believes falls within the scope of this Agreement. The indemnified Party may, at its expense, assist in the defense if it so chooses, provided that the indemnifying Party shall control such defense, and all negotiations relative to the settlement of any such claim. Any settlement intended to bind the indemnified Party shall not be final without the indemnified Party's written consent. Any liability of a Party and its officers, directors, controlling persons, employees or agents shall not exceed the amount of fees actually paid to Consultant by the Company pursuant this Agreement.

Section 9. <u>Miscellaneous.</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Notices</u>.
 All notices under this Agreement shall be in writing. Notices may be served by certified
 or registered mail, postage paid with return receipt requested; by private courier, prepaid;
 by other reliable form of electronic communication; or personally. Mailed notices shall be
 deemed delivered five (5) days after mailing, properly addressed. Couriered notices shall
 be deemed delivered on the date that the courier warrants that delivery will occur. Electronic
 communication notices shall be deemed delivered when receipt is either confirmed by confirming
 transmission equipment or acknowledged by the addressee or its office. Personal delivery
 shall be effective when accomplished. Any Party may change its address by giving notice,
 in writing, stating its new address, to the other Party. Subject to the forgoing, notices
 shall be sent as follows:

If to the Consultant:

HeartCore Enterprises, Inc.

Attn: Sumitaka Yamamoto

848 Jordan Ave. Apt G

Los Altos CA 94022

Email: kanno@heartcore.co.jp

With a copy, which shall not constitute notice, to:

Anthony L.G., PLLC

Attn: John Cacomanolis

625 N. Flagler Drive, Suite 600

West Palm Beach, FL 33401

Email: JCacomanolis@anthonypllc.com

If to the Company, to:

ICheck Co., Ltd.

Attn: Kenichi Kaneko

1-10-1-5 Yurakucho, Chiyoda-ku,

Tokyo 100-0007, Japan

Email: <u>kaneko@icheck.jp</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Accuracy of Statements</u>. Each Party represents and warrants that no representation or warranty
 contained in this Agreement, and no statement delivered or information supplied to the other
 Party pursuant hereto, contains an untrue statement of material fact or omits to state a
 material fact necessary in order to make the statements or information contained herein or
 therein not misleading. The representations and warranties made in this Agreement will be
 continued and will remain true and complete in all material respects and will survive the
 execution of the transactions contemplated hereby.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Entire Agreement</u>. This Agreement sets forth all the promises, covenants, agreements, conditions
 and understandings between the Parties, and supersedes all prior and contemporaneous agreements,
 understandings, inducements or conditions, expressed or implied, oral or written, except
 as herein or therein contained.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Survival</u>.
 The provisions of Section 8 and Section 9 of this Agreement, and any additional provisions
 as required to effect any of such Sections, shall survive any termination or expiration hereof,
 and provided that no expiration or termination of this Agreement shall excuse a Party for
 any liability for obligations arising prior to such expiration or termination.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Binding Effect; Assignment</u>. This Agreement shall be binding upon and shall inure to the benefit
 of the Parties and their respective successors and permitted assigns. No Party shall have
 any power or any right to assign or transfer, in whole or in part, this Agreement, or any
 of its rights or any of its obligations hereunder, including, without limitation, any right
 to pursue any claim for damages pursuant to this Agreement or the transactions contemplated
 herein, or to pursue any claim for any breach or default of this Agreement, or any right
 arising from the purported assignor's due performance of its obligations hereunder,
 without the prior written consent of the other Party and any such purported assignment in
 contravention of the provisions herein shall be null and void and of no force or effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Amendment</u>.
 Subject to the provisions of Section 4(b) the Parties hereby irrevocably agree that no attempted
 amendment, modification, termination, discharge or change (collectively, "Amendment")
 of this Agreement shall be valid and effective, unless the Parties shall unanimously agree
 in writing to such Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>No Waiver</u>. No waiver of any provision of this Agreement shall be effective unless it is
 in writing and signed by the Party against whom it is asserted, and any such written waiver
 shall only be applicable to the specific instance to which it relates and shall not be deemed
 to be a continuing or future waiver. No failure to exercise and no delay in exercising on
 the part of either of the Parties any right, power or privilege under this Agreement shall
 operate as a waiver of it, nor shall any single or partial exercise of any other right, power
 or privilege preclude any other or further exercise of its exercise of any other right, power
 or privilege

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Gender and Use of Singular and Plural</u>. All pronouns shall be deemed to refer to the masculine,
 feminine, neuter, singular or plural, as the identity of the Party or Parties, or their personal
 representatives, successors and assigns may require.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Headings</u>.
 The article and section headings contained in this Agreement are inserted for convenience
 only and shall not affect in any way the meaning or interpretation of the Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <u>Governing Law; Etc</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) This
 Agreement, and any and all claims, proceedings or causes of action relating to this Agreement
 or arising from this Agreement or the transactions contemplated herein, including, without
 limitation, tort claims, statutory claims and contract claims, shall be interpreted, construed,
 governed and enforced under and solely in accordance with the substantive and procedural
 laws of the State of Delaware, in each case as in effect from time to time and as the same
 may be amended from time to time, and as applied to agreements performed wholly within the
 State of Delaware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) SUBJECT
 TO Section 9(k), ANY LEGAL SUIT, ACTION OR PROCEEDING ARISING OUT OF OR BASED UPON THIS AGREEMENT,
 THE OTHER TRANSACTION DOCUMENTS OR THE CONTEMPLATED TRANSACTIONS SHALL BE INSTITUTED SOLELY
 IN THE FEDERAL COURTS OF THE UNITED STATES OF AMERICA OR THE COURTS OF THE STATE OF CALIFORNIA,
 IN EACH CASE LOCATED IN SANTA CLARA COUNTY, CALIFORNIA, AND EACH PARTY IRREVOCABLY SUBMITS
 TO THE PERSONAL JURISDICTION OF SUCH COURTS IN ANY SUCH SUIT, ACTION OR PROCEEDING. THE PARTIES
 IRREVOCABLY AND UNCONDITIONALLY WAIVE ANY OBJECTION TO THE LAYING OF VENUE OF ANY SUIT, ACTION
 OR ANY PROCEEDING IN SUCH COURTS AND IRREVOCABLY WAIVE AND AGREE NOT TO PLEAD OR CLAIM IN
 ANY SUCH COURT THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN
 BROUGHT IN AN INCONVENIENT FORUM.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) EACH
 PARTY HERETO HEREBY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT
 IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT
 OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS, THE PERFORMANCE THEREOF OR THE FINANCINGS
 CONTEMPLATED THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO
 (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED,
 EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK
 TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO
 HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS
 AND CERTIFICATIONS IN THIS
Section 9(j)(iii).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Each
 of the Parties acknowledge that each has been represented in connection with the signing
 of this waiver by independent legal counsel selected by the respective Party and that such
 Party has discussed the legal consequences and import of this waiver with legal counsel.
 Each of the Parties further acknowledge that each has read and understands the meaning of
 this waiver and grants this waiver knowingly, voluntarily, without duress and only after
 consideration of the consequences of this waiver with legal counsel.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <u>Resolution of Disputes</u>. Except as otherwise provided herein, all controversies, disputes or actions
 between the Parties arising out of this Agreement, including their respective Affiliates,
 owners, officers, directors, agents and employees, arising from or relating to this Agreement
 shall on demand of either Party be submitted for arbitration to in accordance with the rules
 and regulations of the American Arbitration Association. The arbitration shall be conducted
 by one arbitrator jointly selected by each Party who is a party to the Dispute, provided,
 however, that if such Parties are unable to agree on the identity of the arbitrator within
 10 Business Days of commencement of efforts to do so, each Party who is a party to the Dispute
 shall select one arbitrator and the arbitrators so selected shall select a final arbitrator,
 and the final arbitrator shall conduct the arbitration alone. The Parties agree that, in
 connection with any such arbitration proceeding, each shall submit or file any claim which
 would constitute a compulsory counterclaim (as defined by Rule 13 of the Federal Rules of
 Civil Procedures) within the same proceeding as the claim to which it relates. Any such claim
 which is not submitted or filed in such proceeding shall be barred. The arbitrator shall
 be instructed to use every reasonable effort to perform its services within seven days of
 request, and, in any case, as soon as practicable. The Parties agree to be bound by the provisions
 of any limitation on the period of time by which claims must be brought under Delaware law
 or any applicable federal law. The arbitrator(s) shall have the right to award the relief
 which he or she deems proper, consistent with the terms of this Agreement, including compensatory
 damages (with interest on unpaid amounts from due date), injunctive relief, specific performance,
 legal damages and costs. The award and decision of the arbitrator(s) shall be conclusive
 and binding on all Parties, and judgment upon the award may be entered in any court of competent
 jurisdiction. Any right to contest the validity or enforceability of this award shall be
 governed exclusively by the United States Arbitration Act. The arbitration shall be conducted
 in Los Altos, California. The provisions of this Section 9(k) shall continue in full force
 and effect subsequent to and notwithstanding the expiration or termination of this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <u>Severability; Expenses; Further Assurances</u>. If any term, condition or other provision of this Agreement
 is determined by a court of competent jurisdiction to be invalid, illegal or incapable of
 being enforced by any rule of law or public policy, all other terms, conditions and provisions
 of this Agreement shall nevertheless remain in full force and effect so long as the economic
 or legal substance of the transactions contemplated by this Agreement is not affected in
 any manner materially adverse to any Party. Upon such determination that any term or other
 provision is invalid, illegal or incapable of being enforced, the Parties shall negotiate
 in good faith to modify this Agreement so as to effect the original intent of the Parties
 as closely as possible in a mutually acceptable manner in order that the transactions contemplated
 by this Agreement be consummated as originally contemplated to the fullest extent possible.
 Except as otherwise specifically provided in this Agreement, each Party shall be responsible
 for the expenses it may incur in connection with the negotiation, preparation, execution,
 delivery, performance and enforcement of this Agreement. The Parties shall from time to time
 do and perform any additional acts and execute and deliver any additional documents and instruments
 that may be required by Law or reasonably requested by any Party to establish, maintain or
 protect its rights and remedies under, or to effect the intents and purposes of, this Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) <u>Specific Performance</u>. Each Party agrees that irreparable damage would occur if any provision of
 this Agreement were not performed in accordance with the terms hereof and that each Party
 shall be entitled to seek specific performance of the terms hereof in addition to any other
 remedy at law or in equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) <u>Attorneys' Fees</u>. If any Party hereto is required to engage in litigation against any other Party,
 either as plaintiff or as defendant, in order to enforce or defend any rights under this
 Agreement, and such litigation results in a final judgment in favor of such Party ("Prevailing
 Party"), then the party or parties against whom said final judgment is obtained shall
 reimburse the Prevailing Party for all direct, indirect or incidental expenses incurred,
 including, but not limited to, all attorneys' fees, court costs and other expenses
 incurred throughout all negotiations, trials or appeals undertaken in order to enforce the
 Prevailing Party's rights hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) <u>Parties in Interest</u>. This Agreement shall be binding upon and inure solely to the benefit of
 each Party, and nothing in this Agreement, express or implied, is intended to confer upon
 any other person or entity any rights or remedies of any nature whatsoever under or by reason
 of this Agreement other than as specifically set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(p) <u>Execution in Counterparts, Electronic Transmission</u>. This Agreement may be executed in multiple
 counterparts, each of which shall be deemed an original and all of which taken together shall
 be but a single instrument. Counterparts may be delivered via facsimile, electronic mail
 (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000,
 e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall
 be deemed to have been duly and validly delivered and be valid and effective for all purposes.

*[Signatures appear on following page]*

IN WITNESS WHEREOF, the Parties hereto have executed this Agreement as of the Effective Date.

---

| | |
|:---|:---|
| HeartCore Enterprises, Inc. | HeartCore Enterprises, Inc. |
| By: | */s/ Sumitaka Yamamoto* |
| Name: | Sumitaka Yamamoto |
| Title: | Chief Executive Officer |
| ICheck Co.,Ltd. | ICheck Co.,Ltd. |
| By: | */s/ Kenichi Kaneko* |
| Name: | Kenichi Kaneko |
| Title: | Chief Executive Officer |

---

## Exhibit 10.4

**Exhibit 10.4**

**EITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.**

**COMMON STOCK PURCHASE WARRANT**

**ICheck Co., Ltd.**

---

| | |
|:---|:---|
| **Warrant Shares: 39,446, subject to adjustment as set forth herein.** | **Issuance Date: March 13, 2023** |

---

THIS COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received, HeartCore Enterprises, Inc., a Delaware corporation, or its registered assigns (the "Holder") is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Trigger Date (as defined below) and on or prior to the close of business on the tenth anniversary of the Trigger Date (the "Termination Date") but not thereafter, to subscribe for and purchase from ICheck Co., Ltd., a Japanese corporation (the "Company"), the number of shares of capital stock (the "Common Stock") of the Company (as subject to adjustment hereunder, the "Warrant Shares") as set forth above. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2.

Section 1. <u>Definitions; Warrant Shares</u>. Capitalized terms used and not otherwise defined herein shall have the meanings set forth in that certain Consulting and Services Agreement dated as of the issuance date as set forth above (the "Issuance Date") between the Company and the Holder (the "Consulting Agreement"). The Company and the Holder acknowledge and agree that the number of Warrant Shares as set forth above represent 3% of the issued and outstanding Common Stock as of the Issuance Date, and that such number of Warrant Shares shall be subject to adjustment as set forth herein. In addition, for purposes herein, the following terms shall have the following meanings:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) "Fundamental
 Transaction" means (i) the Company, directly or indirectly, in one or more related
 transactions effecting any merger or consolidation of the Company with or into another Person,
 (ii) the Company, directly or indirectly, effecting any sale, lease, license, assignment,
 transfer, conveyance or other disposition of all or substantially all of its assets in one
 or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender
 offer or exchange offer (whether by the Company or another Person) is completed pursuant
 to which holders of Common Stock are permitted to sell, tender or exchange their shares for
 other securities, cash or property and has been accepted by the holders of 50% or more of
 the outstanding shares of Common Stock, (iv) the Company, directly or indirectly, in one
 or more related transactions effecting any reclassification, reorganization or recapitalization
 of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is
 effectively converted into or exchanged for other securities, cash or property, or (v) the
 Company, directly or indirectly, in one or more related transactions consummating a stock
 or share purchase agreement or other business combination (including, without limitation,
 a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person
 or group of Persons whereby such other Person or group acquires more than 50% of the outstanding
 shares of Common Stock (not including any shares of Common Stock held by the other Person
 or other Persons making or party to, or associated or affiliated with the other Persons making
 or party to, such stock or share purchase agreement or other business combination), in each
 of clauses (i) through (v), inclusive, which is not a Restructuring.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) "IPO"
 means any event wherein any class of the Company's stock becomes listed for trading
 on any tier of the NASDAQ Stock Market, the New York Stock Exchange or the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) "SPAC"
 means a special purpose acquisition company whose stock is listed for trading on any tier
 of the NASDAQ Stock Market, the New York Stock Exchange or the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) "Trigger
 Date" means the earlier of the date that either (i) the Company completes its first
 IPO, (ii) the Company consummates a merger or other transaction with a SPAC wherein the Company
 becomes a subsidiary of the SPAC; or (iii) the Company consummates any other Fundamental
 Transaction.

Section 2. <u>Exercise</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Exercise
 of the purchase rights represented by this Warrant may be made, in whole or in part, at any
 time or times on or after Trigger Date and before the Termination Date by delivery to the
 Company (or such other office or agency of the Company as it may designate by notice in writing
 to the registered Holder at the address of the Holder appearing on the books of the Company)
 of a duly executed facsimile copy of the Notice of Exercise Form attached hereto. Within
 two (2) Trading Days (as defined below) following the date of aforesaid exercise, the Holder
 shall deliver the aggregate Exercise Price (if the exercise is pursuant to Section 2(b))
 for the shares specified in the applicable Notice of Exercise by wire transfer or cashier's
 check drawn on a United States bank specified in the applicable Notice of Exercise. Notwithstanding
 anything herein to the contrary (although the Holder may surrender the Warrant to, and receive
 a replacement Warrant from, the Company), the Holder shall not be required to physically
 surrender this Warrant to the Company until the Holder has purchased all of the Warrant Shares
 available hereunder and the Warrant has been exercised in full, in which case, the Holder
 shall surrender this Warrant to the Company for cancellation within three (3) Trading Days
 of the date the final Notice of Exercise is delivered to the Company. Partial exercises of
 this Warrant resulting in purchases of a portion of the total number of Warrant Shares available
 hereunder shall have the effect of lowering the outstanding number of Warrant Shares purchasable
 hereunder in an amount equal to the applicable number of Warrant Shares purchased. The Holder
 and the Company shall maintain records showing the number of Warrant Shares purchased and
 the date of such purchases. The Company shall deliver any objection to any Notice of Exercise
 Form within two (2) Trading Days of delivery of such notice. **The Holder and any assignee, by acceptance of this Warrant, acknowledge and agree that, by reason of the provisions of this paragraph, following the purchase of a portion of the Warrant Shares hereunder, the number of Warrant Shares available for purchase hereunder at any given time may be less than the amount stated on the face hereof.** For purposes herein, the term "Trading Day"
 means any day that shares of Common Stock are listed for trading or quotation on any tier
 of the NASDAQ Stock Market, the New York Stock Exchange or the NYSE American.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Exercise Price</u>. The exercise price per share of the Common Stock under this Warrant shall be $0.01,
 subject to adjustment as described herein (as applicable, the "Exercise Price").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Cashless Exercise</u>. In the event that there is no effective registration statement registering
 the Warrant Shares, or no current prospectus available for the resale of the Warrant Shares
 by the Holder, then this Warrant may also be exercised at the Holder's election, in
 whole or in part, at such time by means of a "cashless exercise" in which the
 Holder shall be entitled to receive a number of Warrant Shares equal to the quotient obtained
 by dividing [(A-B) \* (X)] by (A), where:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) = the Market Price (as defined below) on the Trading Day immediately preceding the date on which Holder elects to exercise this Warrant by means of a "cashless exercise," as set forth in the applicable Notice of Exercise, where the "Market Price" equals the highest traded price of the Common Stock during the one hundred fifty (150) Trading Days prior to the date of the respective Exercise Notice;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) = the Exercise Price of this Warrant, as adjusted hereunder; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(X) = the number of Warrant Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

Notwithstanding anything herein to the contrary, on the Termination Date, unless the Holder notifies the Company otherwise, if there is no effective registration statement registering the Warrant Shares, or no current prospectus available for, the resale of the Warrant Shares by the Holder, then this Warrant shall be automatically exercised via cashless exercise pursuant to this Section 2(c); provided however, that if the automatic exercise contemplated under this Section shall result in a conflict with the beneficial ownership limitations of Section 2(f), the Termination Date shall be extended so long as necessary to provide for full exercise of the Warrant under this Section 2(c).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Anti-Dilution Adjustments to Exercise Price</u>. If the Company or any Subsidiary (as defined below) thereof,
 as applicable, at any time while this Warrant is outstanding, shall sell or grant any option
 to purchase, or sell or grant any right to reprice, or otherwise dispose of or issue (or
 announce any offer, sale, grant or any option to purchase or other disposition) any Common
 Stock or securities entitling any person or entity (for purposes of clarification, including
 but not limited to the Holder pursuant to (i) any other security of the Company issued
 to Holder on or after the Issuance Date or (ii) any other agreement entered into between
 the Company and Holder) to acquire shares of Common Stock (upon conversion, exercise or otherwise),
 at an effective price per share less than the then Exercise Price (such lower price, the
 "Base Share Price" and such issuances collectively, a "Dilutive Issuance")
 (if the holder of the Common Stock or Common Stock Equivalents (as defined below) so issued
 shall at any time, whether by operation of purchase price adjustments, elimination of an
 applicable floor price for any reason in the future (including but not limited to the passage
 of time or satisfaction of certain condition(s)), reset provisions, floating conversion,
 exercise or exchange prices or otherwise, or due to warrants, options or rights per share
 which are issued in connection with such issuance, be entitled or potentially entitled to
 receive shares of Common Stock at an effective price per share which is less than the Exercise
 Price at any time while such Common Stock or Common Stock Equivalents are in existence, such
 issuance shall be deemed to have occurred for less than the Exercise Price on such date of
 the Dilutive Issuance (regardless of whether the Common Stock or Common Stock Equivalents
 are (i) subsequently redeemed or retired by the Company after the date of the Dilutive Issuance
 or (ii) actually converted or exercised at such Base Share Price), then the Exercise Price
 shall be reduced at the option of the Holder and only reduced to equal the Base Share Price.
 Such adjustment shall be made whenever such Common Stock or Common Stock Equivalents are
 issued, regardless of whether the Common Stock or Common Stock Equivalents are (i) subsequently
 redeemed or retired by the Company after the date of the Dilutive Issuance or (ii) actually
 converted or exercised at such Base Share Price by the holder thereof (for the avoidance
 of doubt, the Holder may utilize the Base Share Price even if the Company did not actually
 issue shares of its common stock at the Base Share Price under the respective Common stock
 Equivalents). The Company shall notify the Holder in writing, no later than the Trading Day
 following the issuance of any Common Stock or Common Stock Equivalents subject to this Section
 2(d), indicating therein the applicable issuance price, or applicable reset price, exchange
 price, conversion price and other pricing terms (such notice the "Dilutive Issuance
 Notice"). For purposes of clarification, whether or not the Company provides a Dilutive
 Issuance Notice pursuant to this Section 2(d), upon the occurrence of any Dilutive Issuance,
 after the date of such Dilutive Issuance the Holder is entitled to receive a number of Warrant
 Shares based upon the Base Share Price regardless of whether the Holder accurately refers
 to the Base Share Price in the Notice of Exercise. "Common Stock Equivalents"
 means any securities of the Company or the Subsidiaries which would entitle the holder thereof
 to acquire at any time Common Stock, including, without limitation, any debt, preferred stock,
 right, option, warrant or other instrument that is at any time convertible into or exercisable
 or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. For
 purposes herein, "Subsidiaries" means any corporation or other organization,
 whether incorporated or unincorporated, in which the Company owns, directly or indirectly,
 any equity or other ownership interest.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Mechanics of Exercise</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Delivery of Certificates Upon Exercise</u>. Certificates for shares purchased hereunder shall be transmitted
 by the Company's then-engaged transfer agent (the "Transfer Agent") to
 the Holder by crediting the account of the Holder's prime broker with The Depository
 Trust Company through its Deposit or Withdrawal at Custodian system (" <u>DWAC</u> ")
 if the Company is then a participant in such system and there is an effective registration
 statement permitting the issuance of the Warrant Shares to, or resale of the Warrant Shares,
 by the Holder and otherwise by physical delivery to the address specified by the Holder in
 the Notice of Exercise by the date that is two (2) Trading Days after the delivery to the
 Company of the Notice of Exercise, (such date, the "Warrant Share Delivery Date").
 The Warrant Shares shall be deemed to have been issued, and Holder or any other person so
 designated to be named therein shall be deemed to have become a holder of record of such
 shares for all purposes, as of the date the Warrant has been exercised, with payment to the
 Company of the Exercise Price and all taxes required to be paid by the Holder, if any, prior
 to the issuance of such shares, having been paid. The Company understands that a delay in
 the delivery of the Warrant Shares after the Warrant Share Delivery Date could result in
 economic loss to the Holder. As compensation to the Holder for such loss, the Company agrees
 to pay (as liquidated damages and not as a penalty) to the Holder for late issuance of Warrant
 Shares upon exercise of this Warrant the amount of $1,000.00 per Trading Day. The Company
 shall pay any payments incurred under this Section 2(e) in immediately available funds, or
 shares of Common Stock of the Company, in the Holder's discretion, upon demand. Furthermore,
 in addition to any other remedies which may be available to the Holder, in the event that
 the Company fails for any reason to effect delivery of the Warrant Shares by the Warrant
 Share Delivery Date, the Holder may revoke all or part of the relevant Warrant exercise by
 delivery of a notice to such effect to the Company, whereupon the Company and the Holder
 shall each be restored to their respective positions immediately prior to the exercise of
 the relevant portion of this Warrant, except that the liquidated damages described above
 shall be payable through the date notice of revocation or rescission is given to the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Delivery of New Warrants Upon Exercise</u>. If this Warrant shall have been exercised in part, the
 Company shall, at the request of Holder and upon surrender of this Warrant certificate, at
 the time of delivery of the certificate or certificates representing Warrant Shares, deliver
 to the Holder a new Warrant evidencing the rights of the Holder to purchase the unpurchased
 Warrant Shares called for by this Warrant, which new Warrant shall in all other respects
 be identical with this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Rescission Rights</u>. If the Company fails to cause the Transfer Agent to transmit to the Holder a
 certificate or the certificates representing the Warrant Shares by the Warrant Share Delivery
 Date, then the Holder will have the right, at any time prior to issuance of such Warrant
 Shares, to rescind such exercise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) <u>Compensation for Buy-In on Failure to Timely Deliver Certificates Upon Exercise</u>. In addition to any
 other rights available to the Holder, if the Company fails to cause the Transfer Agent to
 transmit to the Holder a certificate or the certificates representing the Warrant Shares
 pursuant to an exercise on or before the Warrant Share Delivery Date, and if after such date
 the Holder is required by its broker to purchase (in an open market transaction or otherwise),
 or the Holder's brokerage firm otherwise purchases, shares of Common Stock to deliver
 in satisfaction of a sale by the Holder of the Warrant Shares which the Holder anticipated
 receiving upon such exercise (a "Buy-In"), then the Company shall (A) pay in
 cash to the Holder the amount, if any, by which (x) the Holder's total purchase price
 (including brokerage commissions, if any) for the shares of Common Stock so purchased exceeds
 (y) the amount obtained by multiplying (1) the number of Warrant Shares that the Company
 was required to deliver to the Holder in connection with the exercise at issue times (2)
 the price at which the sell order giving rise to such purchase obligation was executed, and
 (B) at the option of the Holder, either reinstate the portion of the Warrant and equivalent
 number of Warrant Shares for which such exercise was not honored (in which case such exercise
 shall be deemed rescinded) or deliver to the Holder the number of shares of Common Stock
 that would have been issued had the Company timely complied with its exercise and delivery
 obligations hereunder. For example, if the Holder purchases Common Stock having a total purchase
 price of $11,000.00 to cover a Buy-In with respect to an attempted exercise of shares of
 Common Stock with an aggregate sale price giving rise to such purchase obligation of $10,000.00,
 under clause (A) of the immediately preceding sentence the Company shall be required to pay
 the Holder $1,000.00. The Holder shall provide the Company written notice indicating the
 amounts payable to the Holder in respect of the Buy-In and, upon request of the Company,
 evidence of the amount of such loss. Nothing herein shall limit Holder's right to pursue
 any other remedies available to it hereunder, at law or in equity including, without limitation,
 a decree of specific performance and/or injunctive relief with respect to the Company's
 failure to timely deliver certificates representing shares of Common Stock upon exercise
 of the Warrant as required pursuant to the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v) <u>No Fractional Shares or Scrip</u>. No fractional shares or scrip representing fractional shares
 shall be issued upon the exercise of this Warrant. As to any fraction of a share which the
 Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at
 its election, either pay a cash adjustment in respect of such final fraction in an amount
 equal to such fraction multiplied by the Exercise Price or round up to the next whole share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vi) <u>Charges, Taxes and Expenses</u>. Issuance of certificates for Warrant Shares shall be made without
 charge to the Holder for any issue or transfer tax or other incidental expense in respect
 of the issuance of such certificate, all of which taxes and expenses shall be paid by the
 Company, and such certificates shall be issued in the name of the Holder or in such name
 or names as may be directed by the Holder; provided, however, that in the event certificates
 for Warrant Shares are to be issued in a name other than the name of the Holder, this Warrant
 when surrendered for exercise shall be accompanied by the Assignment Form attached hereto
 duly executed by the Holder and the Company may require, as a condition thereto, the payment
 of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
 shall pay all Transfer Agent fees required for same-day processing of any Notice of Exercise.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(vii) <u>Closing of Books</u>. The Company will not close its stockholder books or records in any manner which
 prevents the timely exercise of this Warrant, pursuant to the terms hereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Holder's Exercise Limitations</u>. From and after the date that the Warrant Shares are of a class
 of equity of the borrower registered under Section 12(g) of the Exchange Act or the Company
 is subject to the reporting requirements of Section 13 or Section 15(d) of the Exchange Act,
 the Company shall not effect any exercise of this Warrant, and Holder shall not have the
 right to exercise any portion of this Warrant, to the extent that after giving effect to
 such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder
 (together with the Holder's affiliates, and any other Persons acting as a group together
 with the Holder or any of the Holder's affiliates), would beneficially own in excess
 of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing
 sentence, the number of shares of Common Stock beneficially owned by the Holder and its affiliates
 shall include the number of shares of Common Stock issuable upon exercise of this Warrant
 with respect to which such determination is being made, but shall exclude the number of shares
 of Common Stock which would be issuable upon (i) exercise of the remaining, nonexercised
 portion of this Warrant beneficially owned by the Holder or any of its affiliates and (ii)
 exercise or conversion of the unexercised or nonconverted portion of any other securities
 of the Company (including, without limitation, any other Common Stock Equivalents) subject
 to a limitation on conversion or exercise analogous to the limitation contained herein beneficially
 owned by the Holder or any of its affiliates. Except as set forth in the preceding sentence,
 for purposes of this Section 2(f), beneficial ownership shall be calculated in accordance
 with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder,
 it being acknowledged by the Holder that the Company is not representing to the Holder that
 such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is
 solely responsible for any schedules required to be filed in accordance therewith. To the
 extent that the limitation contained in this Section 2(f) applies, the determination of whether
 this Warrant is exercisable (in relation to other securities owned by the Holder together
 with any affiliates) and of which portion of this Warrant is exercisable shall be in the
 sole discretion of the Holder, and the submission of a Notice of Exercise shall be deemed
 to be the Holder's determination of whether this Warrant is exercisable (in relation
 to other securities owned by the Holder together with any affiliates) and of which portion
 of this Warrant is exercisable, in each case subject to the Beneficial Ownership Limitation,
 and the Company shall have no obligation to verify or confirm the accuracy of such determination.
 In addition, a determination as to any group status as contemplated above shall be determined
 in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated
 thereunder. For purposes of this Section 2(f), in determining the number of outstanding shares
 of Common Stock, Holder may rely on the number of outstanding shares of Common Stock as reflected
 in (A) the Company's most recent periodic or annual report filed with the Commission,
 as the case may be, (B) a more recent public announcement by the Company or (C) a more recent
 written notice by the Company or the Transfer Agent setting forth the number of shares of
 Common Stock outstanding. Upon the written or oral request of Holder, the Company shall within
 two Trading Days confirm orally and in writing to the Holder the number of shares of Common
 Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall
 be determined after giving effect to the conversion or exercise of securities of the Company,
 including this Warrant, by the Holder or its affiliates since the date as of which such number
 of outstanding shares of Common Stock was reported. The "Beneficial Ownership Limitation"
 shall be 9.99% of the number of shares of the Common Stock outstanding immediately after
 giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant.
 The Holder may decrease the Beneficial Ownership Limitation at any time and the Holder, upon
 not less than sixty-one (61) days' prior notice to the Company, may increase or waive
 the Beneficial Ownership Limitation provisions of this Section 2(f), provided that any such
 increase or waiver will not be effective until the 61<sup>st</sup> day after such notice
 is delivered to the Company. The provisions of this paragraph shall be construed and implemented
 in a manner otherwise than in strict conformity with the terms of this Section 2(f) to correct
 this paragraph (or any portion hereof) which may be defective or inconsistent with the intended
 Beneficial Ownership Limitation herein contained or to make changes or supplements necessary
 or desirable to properly give effect to such limitation. The limitations contained in this
 paragraph shall apply to a successor holder of this Warrant.

Section 3. <u>Certain Adjustments and Revisions to Warrant</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Fundamental Transaction</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Transaction</u>.
 If, at any time while this Warrant is outstanding, the Company consummates any Fundamental
 Transaction, then, upon any subsequent exercise of this Warrant, the Holder shall have the
 right to receive, for each Warrant Share that would have been issuable upon such exercise
 immediately prior to the occurrence of such Fundamental Transaction, at the option of the
 Holder, the number of shares of common stock of the successor or acquiring corporation (the
 "Successor Entity"), of the Company, if it is the surviving corporation, and
 any additional consideration (the "Alternate Consideration") receivable as a
 result of such Fundamental Transaction by a holder of the number of shares of Common Stock
 for which this Warrant is exercisable immediately prior to such Fundamental Transaction,
 and any references herein to the "Company", whether standing alone or as a part
 of any other defined term, shall be deemed a reference to the successor or acquiring corporation
 in the Fundamental Transaction, or the Company if it is the surviving corporation, and this
 Warrant shall be so exercisable with respect to the Successor Entity or the Company, as applicable.
 For purposes of any such exercise, the determination of the Exercise Price shall be appropriately
 adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration
 issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
 Company shall apportion the Exercise Price among the Alternate Consideration in a reasonable
 manner reflecting the relative value of any different components of the Alternate Consideration.
 If holders of Common Stock are given any choice as to the securities, cash or property to
 be received in a Fundamental Transaction, then the Holder shall be given the same choice
 as to the Alternate Consideration it receives upon any exercise of this Warrant following
 such Fundamental Transaction. If so requested by the Company, the Successor Entity or the
 Holder, each of the Company, the Successor Entity and the Holder shall reasonably cooperate
 to execute and deliver such agreements and documents as required to effect the intent of
 the provisions of this Section 3(a) and the other provisions herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Holder Election</u>. In the event that a Fundamental Transaction occurs prior to the full exercise
 of this Warrant, the Holder, in its sole discretion and as evidenced by written notice to
 the Company and the Successor Entity, if applicable, at any time shall have the right to
 elect to cause the Company and the Successor Entity, if applicable, to issue to Holder a
 new warrant of the Company or the Successor Entity (the "Fundamental Transaction Replacement
 Warrant"), which Fundamental Transaction Replacement Warrant shall be issued within
 three business days of such election by Holder, and shall reflect the terms and conditions
 herein following the effects of this Section 3(a), and the other provisions herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Terms of Replacement Warrant</u>. The Fundamental Transaction Replacement Warrant shall be substantially
 in the form of this Warrant (other than the last sentence of Section 5(e) shall be omitted,
 and such additional changes as reasonably required to reflect any Successor Entity as the
 issuer shall be made), and shall provide for the acquisition of the stock of the Company
 and the Successor Entity, as applicable, and will be for a number of shares of the Company
 and the Successor Entity comprising the number of shares of the Company and the Successor
 Entity into which 3% of the shares of the Company as of the Issuance Date as set forth above
 were converted or exchanged in the Fundamental Transaction, less any proportion of this Warrant
 which has been exercised as of the time of the issuance of the Fundamental Transaction Replacement
 Warrant. By way of example and not limitation, in the event that this Warrant was initially
 exercisable for 1,000 shares of the Company and the Company had 100,000 shares outstanding,
 and assuming no portion of this Warrant had been exercised, if all 100,000 shares of the
 Company were converted or exchanged in a Fundamental Transaction for 1,000,000 shares of
 the Successor Entity, the Fundamental Transaction Replacement Warrant would be exercisable
 for 10,000 shares of the Successor Entity. The Fundamental Transaction Replacement Warrant
 shall be governed by the laws of the jurisdiction of organization of the Company or the Successor
 Entity, as applicable. Upon any issuance of the Fundamental Transaction Replacement Warrant,
 this Warrant shall thereafter be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Restructuring</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>New Entity</u>. In addition to the other provisions herein, the Company and the Holder acknowledge
 and agree that, in connection with preparations for a Trigger Event, it is expected that
 the Company may create a new corporation in the United States, which is expected to be in
 the State of Delaware ("Newco"), to undertake the Trigger Event, and in which
 event the Company is expected to be acquired by, or merge with, Newco or a subsidiary of
 Newco, such that Newco will be the entity that completes the Trigger Event (the "Restructuring").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Holder Election</u>. In the event that the Restructuring is completed prior to the full exercise
 of this Warrant, the Holder, in its sole discretion and as evidenced by written notice to
 the Company at any time prior to or following the completion of the Restructuring, shall
 have the right to elect to cause the Company and Newco to issue to Holder a new warrant of
 Newco to replace this Warrant (the "Restructuring Replacement Warrant"), which
 Restructuring Replacement Warrant shall be issued within three business days of such election
 by Holder, and shall reflect the terms and conditions herein following the effects of this
 Section 3(b), and the other provisions herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) <u>Terms of Restructuring Replacement Warrant</u>. The Restructuring Replacement Warrant shall be
 substantially in the form of this Warrant (other than the last sentence of Section 5(e) shall
 be omitted, and such additional changes as reasonably required to reflect the Newco as the
 issuer shall be made), and shall provide for the acquisition of the stock of Newco, and will
 be for a number of shares of Newco comprising the number of shares of Newco into which 3%
 of the shares of the Company as of the Issuance Date as set forth above were converted or
 exchanged in the Restructuring, less any proportion of this Warrant which has been exercised
 as of the time of the issuance of the Restructuring Replacement Warrant. By way of example
 and not limitation, in the event that this Warrant was initially exercisable for 1,000 shares
 of the Company and the Company had 100,000 shares outstanding, and assuming no portion of
 this Warrant had been exercised, if all 100,000 shares of the Company were converted or exchanged
 in an Restructuring for 1,000,000 shares of Newco, the Restructuring Replacement Warrant
 would be exercisable for 10,000 shares of Newco. The Restructuring Replacement Warrant shall
 be governed by the laws of the jurisdiction of organization of Newco. Upon any issuance of
 the Restructuring Replacement Warrant, this Warrant shall thereafter be null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Adjustment of Warrant Shares</u>. The number of Warrant Shares for which this Warrant shall be exercisable
 shall be automatically adjusted on the Trigger Date to be 3% of the fully diluted number
 and class of shares of capital stock of the Company or any Successor Entity, as applicable,
 as of the Trigger Date, following completion of the transactions which caused the Trigger
 Date to be achieved.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Stock Dividends and Splits</u>. If the Company, at any time while this Warrant is outstanding:
 (i) pays a stock dividend or otherwise makes a distribution or distributions on shares of
 its Common Stock or any other equity or equity equivalent securities payable in shares of
 Common Stock; (ii) subdivides outstanding shares of Common Stock into a larger number of
 shares; (iii) combines (including by way of reverse stock split) outstanding shares of Common
 Stock into a smaller number of shares; or (iv) issues by reclassification of shares of the
 Common Stock any shares of capital stock of the Company, then in each case the Exercise Price
 shall be multiplied by a fraction of which the numerator shall be the number of shares of
 Common Stock (excluding treasury shares, if any) outstanding immediately before such event
 and of which the denominator shall be the number of shares of Common Stock outstanding immediately
 after such event, and the number of shares issuable upon exercise of this Warrant shall be
 proportionately adjusted such that the aggregate Exercise Price of this Warrant shall remain
 unchanged. Any adjustment made pursuant to this Section 3(a) shall become effective immediately
 after the record date for the determination of stockholders entitled to receive such dividend
 or distribution and shall become effective immediately after the effective date in the case
 of a subdivision, combination or re-classification.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Non-Circumvention</u>.
 The intent of the provisions of this Section 3 is that the Holder will be entitled to acquire
 shares of stock in the entity in which or through which the Company consummates any Trigger
 Event, whether following a Restructuring or not, and whether being the Company, Newco or
 any Successor Entity, and the Company shall not undertake any actions or fail to take any
 actions which would reasonably be expected to frustrate such intent, and shall take such
 actions as reasonably required to effect such intent.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Voluntary Reduction</u>. The Company may unilaterally reduce the Exercise Price at any time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>Calculations</u>.
 All calculations under this Section 3 shall be made to the nearest cent or the nearest 1/100th
 of a share, as the case may be. For purposes of this Section 3, the number of shares of Common
 Stock deemed to be issued and outstanding as of a given date shall be the sum of the number
 of shares of Common Stock (excluding treasury shares, if any) issued and outstanding. For
 the avoidance of doubt, the adjustments to the number of Warrant Shares and to the Exercise
 Price as set forth in each of Section 2(d), Section 3(a), Section 3(b), Section 3(c) and
 Section 3(d), and any other adjustment or modification provisions herein, shall each operate
 independently of each other, and cumulatively.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Notice to Holder</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Adjustments</u>.
 Whenever the Exercise Price or the number of Warrant Shares is adjusted pursuant to any provision
 in this Warrant, or in the event of any Fundamental Transaction or Restructuring, the Company
 shall promptly mail to the Holder a notice setting forth the Exercise Price and the number
 of Warrant Shares after such adjustment and setting forth a brief statement of the facts
 requiring such adjustment.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) <u>Notice to Allow Exercise by Holder</u>. If (A) the Company shall declare a dividend (or any other distribution in whatever form) on the Common
 Stock; (B) the Company shall declare a special nonrecurring cash dividend on, or a redemption of, the Common Stock; (C) the Company
 shall authorize the granting to all holders of the Common Stock rights or warrants to subscribe for or purchase any shares of capital
 stock of any class or of any rights; (D) the approval of any stockholders of the Company shall be required in connection with any reclassification
 of the Common Stock, any consolidation or merger to which the Company is a party, any sale or transfer of all or substantially all
 of the assets of the Company, or any compulsory share exchange whereby the Common Stock is converted into other securities; or (E)
 the Company shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the Company, then,
 in each case, to the extent that such information constitutes material non-public information (as determined in good faith by the Company)
 the Company shall follow the procedure described the Consulting Agreement and shall deliver to the Holder at its last address as it
 shall appear upon the Warrant Register of the Company, at least twenty (20) calendar days prior to the applicable record or effective
 date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose of such dividend, distribution,
 redemption, rights or warrants, or if a record is not to be taken, the date as of which the holders of the Common Stock of record to
 be entitled to such dividend, distributions, redemption, rights or warrants are to be determined or (y) the date on which such reclassification,
 consolidation, merger, sale, transfer or share exchange is expected to become effective or close, and the date as of which it is expected
 that holders of the Common Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other
 property deliverable upon such reclassification, consolidation, merger, sale, transfer or share exchange; provided that the failure
 to mail such notice or any defect therein or in the mailing thereof shall not affect the validity of the corporate action required
 to be specified in such notice. To the extent that any notice provided hereunder constitutes, or contains, material, non-public information
 regarding the Company or any of the Subsidiaries, the Company shall simultaneously file such notice with the SEC pursuant to a Current
 Report on Form 8-K. The Holder shall remain entitled to exercise this Warrant during the period commencing on the date of such notice
 to the effective date of the event triggering such notice except as may otherwise be expressly set forth herein.

Section 4. <u>Transfer of Warrant</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>Transferability</u>.
 Subject to compliance with any applicable securities laws, this Warrant and all rights hereunder
 (including, without limitation, any registration rights) are transferable, in whole or in
 part, upon surrender of this Warrant at the principal office of the Company or its designated
 agent, together with a written assignment of this Warrant substantially in the form attached
 hereto duly executed by the Holder or its agent or attorney and funds sufficient to pay any
 transfer taxes payable upon the making of such transfer. Upon such surrender and, if required,
 such payment, the Company shall execute and deliver a new Warrant or Warrants in the name
 of the assignee or assignees, as applicable, and in the denomination or denominations specified
 in such instrument of assignment, and shall issue to the assignor a new Warrant evidencing
 the portion of this Warrant not so assigned, and this Warrant shall promptly be cancelled.
 The Warrant, if properly assigned in accordance herewith, may be exercised by a new holder
 for the purchase of Warrant Shares without having a new Warrant issued.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>New Warrants</u>. Subject to compliance with all applicable securities laws, this Warrant may
 be divided or combined with other Warrants upon presentation hereof at the aforesaid office
 of the Company, together with a written notice specifying the names and denominations in
 which new Warrants are to be issued, signed by the Holder or its agent or attorney. Subject
 to compliance with Section 4(a), as to any transfer which may be involved in such division
 or combination, the Company shall execute and deliver a new Warrant or Warrants in exchange
 for the Warrant or Warrants to be divided or combined in accordance with such notice. All
 Warrants issued on transfers or exchanges shall be dated the initial issuance date of this
 Warrant and shall be identical with this Warrant except as to the number of Warrant Shares
 issuable pursuant thereto.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Warrant Register</u>. The Company shall register this Warrant, upon records to be maintained by the
 Company for that purpose (the "Warrant Register"), in the name of the record
 Holder hereof from time to time. The Company may deem and treat the registered Holder of
 this Warrant as the absolute owner hereof for the purpose of any exercise hereof or any distribution
 to the Holder, and for all other purposes, absent actual notice to the contrary.

Section 5. <u>Miscellaneous</u>.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) <u>No Rights as Stockholder Until Exercise</u>. This Warrant does not entitle the Holder to any
 voting rights, dividends or other rights as a stockholder of the Company prior to the exercise
 hereof as set forth herein.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) <u>Loss, Theft, Destruction or Mutilation of Warrant</u>. The Company covenants that upon receipt
 by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction
 or mutilation of this Warrant or any stock certificate relating to the Warrant Shares, and
 in case of loss, theft or destruction, of indemnity or security reasonably satisfactory to
 it (which shall not include the posting of any bond), and upon surrender and cancellation
 of such Warrant or stock certificate, if mutilated, the Company will make and deliver a new
 Warrant or stock certificate of like tenor and dated as of such cancellation, in lieu of
 such Warrant or stock certificate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) <u>Saturdays, Sundays, Holidays, etc</u>. If the last or appointed day for the taking of any action or
 the expiration of any right required or granted herein shall not be a Trading Day, then,
 such action may be taken or such right may be exercised on the next succeeding Trading Day.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) <u>Authorized Shares</u>. The Company covenants that, during the period the Warrant is outstanding, it
 will reserve from its authorized and unissued Common Stock a sufficient number of shares
 to provide for the issuance of the Warrant Shares upon the exercise of any purchase rights
 under this Warrant, which number shall be at least 300% of the number of Warrant Shares to
 be issued upon exercise of this Warrant. The Company further covenants that its issuance
 of this Warrant shall constitute full authority to its officers who are charged with the
 duty of executing stock certificates to execute and issue the necessary certificates for
 the Warrant Shares upon the exercise of the purchase rights under this Warrant. The Company
 will take all such reasonable action as may be necessary to assure that such Warrant Shares
 may be issued as provided herein without violation of any applicable law or regulation, or
 of any requirements of the trading market upon which the Common Stock may be listed. The
 Company covenants that all Warrant Shares which may be issued upon the exercise of the purchase
 rights represented by this Warrant will, upon exercise of the purchase rights represented
 by this Warrant and payment for such Warrant Shares in accordance herewith, be duly authorized,
 validly issued, fully paid and non-assessable and free from all taxes, liens and charges

 transfer occurring contemporaneously with such issue). Except and to the extent as waived
 or consented to by the Holder, the Company shall not by any action, including, without limitation,
 amending its certificate of incorporation or through any reorganization, transfer of assets,
 consolidation, merger, dissolution, issue or sale of securities or any other voluntary action,
 avoid or seek to avoid the observance or performance of any of the terms of this Warrant,
 but will at all times in good faith assist in the carrying out of all such terms and in the
 taking of all such actions as may be necessary or appropriate to protect the rights of Holder
 as set forth in this Warrant against impairment. Without limiting the generality of the foregoing,
 the Company will (i) not increase the par value of any Warrant Shares above the amount payable
 therefor upon such exercise immediately prior to such increase in par value; (ii) take all
 such action as may be necessary or appropriate in order that the Company may validly and
 legally issue fully paid and nonassessable Warrant Shares upon the exercise of this Warrant;
 and (iii) use commercially reasonable efforts to obtain all such authorizations, exemptions
 or consents from any public regulatory body having jurisdiction thereof, as may be, necessary
 to enable the Company to perform its obligations under this Warrant. Before taking any action
 which would result in an adjustment in the number of Warrant Shares for which this Warrant
 is exercisable or in the Exercise Price, the Company shall obtain all such authorizations
 or exemptions thereof, or consents thereto, as may be necessary from any public regulatory
 body or bodies having jurisdiction thereof. Failure to maintain sufficient shares for exercise
 of the Warrant, shall constitute an Event of Default under the Consulting Agreement and Holder
 shall be able to rely on any applicable default remedies thereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) <u>Governing Law and Jurisdiction</u>. This Warrant, and any and all claims, proceedings or causes of
 action relating to this Warrant or arising from this Warrant or the transactions contemplated
 herein, including, without limitation, tort claims, statutory claims and contract claims,
 shall be interpreted, construed, governed and enforced under and solely in accordance with
 the substantive and procedural laws of the State of Delaware, in each case as in effect from
 time to time and as the same may be amended from time to time, and as applied to agreements
 performed wholly within the State of Delaware. All questions concerning jurisdiction, venue
 and the construction, validity, enforcement and interpretation of this Warrant shall be determined
 in accordance with the provisions of the Consulting Agreement. Notwithstanding the foregoing,
 to the extent that the laws of Japan are required to apply hereto in order to give effect
 hereto, the laws of Japan shall so apply.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) <u>Restrictions</u>.
 The Holder acknowledges that the Warrant Shares acquired upon the exercise of this Warrant,
 if not registered, will have restrictions upon resale imposed by state and federal securities
 laws.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) <u>Non-waiver and Expenses</u>. No course of dealing or any delay or failure to exercise any right hereunder
 on the part of Holder shall operate as a waiver of such right or otherwise prejudice the
 Holder's rights, powers or remedies. Without limiting any other provision of this Warrant
 or the Consulting Agreement, if the Company fails to comply with any provision of this Warrant,
 which results in any material damages to the Holder, the Company shall pay to the Holder
 such amounts as shall be sufficient to cover any costs and expenses including, but not limited
 to, reasonable attorneys' fees, including those of appellate proceedings, incurred
 by the Holder in collecting any amounts due pursuant hereto or in otherwise enforcing any
 of its rights, powers or remedies hereunder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) <u>Notices</u>.
 Any notice, request or other document required or permitted to be given or delivered to the
 Holder by the Company shall be delivered in accordance with the notice provisions of the
 Consulting Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) <u>Limitation of Liability</u>. No provision hereof, in the absence of any affirmative action by the Holder
 to exercise this Warrant to purchase Warrant Shares, and no enumeration herein of the rights
 or privileges of the Holder, shall give rise to any liability of the Holder for the purchase
 price of any Common Stock or as a stockholder of the Company, whether such liability is asserted
 by the Company or by creditors of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) <u>Remedies</u>.
 The Holder, in addition to being entitled to exercise all rights granted by law, including
 recovery of damages, will be entitled to specific performance of its rights under this Warrant.
 The Company agrees that monetary damages would not be adequate compensation for any loss
 incurred by reason of a breach by it of the provisions of this Warrant and hereby agrees
 to waive and not to assert the defense in any action for specific performance that a remedy
 at law would be adequate.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) <u>Successors and Assigns</u>. Subject to applicable securities laws, this Warrant and the rights and obligations
 evidenced hereby shall inure to the benefit of and be binding upon the successors and permitted
 assigns of the Company and the successors and permitted assigns of Holder. The provisions
 of this Warrant are intended to be for the benefit of any Holder from time to time of this
 Warrant and shall be enforceable by the Holder or holder of Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) <u>Amendment</u>.
 Other than as specifically set forth herein, this Warrant may be modified or amended or the
 provisions hereof waived only with the written consent of the Company and the Holder.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) <u>Severability</u>.
 Wherever possible, each provision of this Warrant shall be interpreted in such manner as
 to be effective and valid under applicable law, but if any provision of this Warrant shall
 be prohibited by or invalid under applicable law, such provision shall be ineffective to
 the extent of such prohibition or invalidity, without invalidating the remainder of such
 provisions or the remaining provisions of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(n) <u>Headings</u>.
 The headings used in this Warrant are for the convenience of reference only and shall not,
 for any purpose, be deemed a part of this Warrant.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(o) <u>Execution in Counterparts, Electronic Transmission</u>. This Warrant may be executed in multiple counterparts,
 each of which shall be deemed an original and all of which taken together shall be but a
 single instrument. Counterparts may be delivered via facsimile, electronic mail (including
 pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, e.g.,
 www.docusign.com) or other transmission method and any counterpart so delivered shall be
 deemed to have been duly and validly delivered and be valid and effective for all purposes.

*[Signatures appear on following page]*

IN WITNESS WHEREOF, the Company has caused this Warrant to be executed by its officer thereunto duly authorized as of Issuance Date.

---

| | |
|:---|:---|
| ICheck Co., Ltd. | ICheck Co., Ltd. |
| By: | */s/ Kenichi Kaneko* |
| Name: | Kenichi Kaneko |
| Title: | Chief Executive Officer |

---

---

| | |
|:---|:---|
| *Agreed and accepted:* | *Agreed and accepted:* |
| HeartCore Enterprises, Inc. | HeartCore Enterprises, Inc. |
| By: | */s/ Sumitaka Yamamoto* |
| Name: | Sumitaka Yamamoto |
| Title: | Chief Executive Officer |

---

**NOTICE OF EXERCISE**

TO: ICheck Co., Ltd.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The undersigned hereby elects to purchase______________Warrant Shares of the Company pursuant to the terms of the attached Warrant (only if exercised in full), and tenders herewith payment of the exercise price in full, together with all applicable transfer taxes, if any.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Payment shall take the form of lawful money of the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Please issue a certificate or certificates representing said Warrant Shares in the name of the undersigned or in such other name as is specified below:

________________________________

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) After giving effect to this Notice of Exercise, the undersigned will not have exceeded the Beneficial Ownership Limitation.

The Warrant Shares shall be delivered to the following DWAC Account Number or by physical delivery of a certificate to:

________________________________________

________________________________________

________________________________________

________________________________________

Name of Investing Entity:

________________________________________

*Signature of Authorized Signatory of Investing Entity*:

________________________________________

Name:

Title:

Date:

**ASSIGNMENT FORM**

(To assign the foregoing warrant, execute this form and supply required information. Do not use this form to exercise the warrant.)

ICheck Co., Ltd.

FOR VALUE RECEIVED, [ ___________ ] all of or [ ___________ ] shares of the foregoing Warrant and all rights evidenced thereby are hereby assigned to _________________________________________________whose address is

________________________________________________________________________.

Dated: ___________________________________________________________________, _________

---

| | |
|:---|:---|
| Holder's Signature: | ___________________________________ |
| Holder's Address: | ___________________________________ |
|  | ___________________________________ |

---

Signed in the presence of:

_______________________________

NOTE: The signature to this Assignment Form must correspond with the name as it appears on the face of the Warrant, without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank or trust company. Officers of corporations and those acting in a fiduciary or other representative capacity should file proper evidence of authority to assign the foregoing Warrant.

## Exhibit 99.1

**Exhibit 99.1**

![](ex99-1_001.jpg)

**HeartCore Provides Strong Go IPO Updates**

 

*-Company Expects to Receive Approximately $32.4 Million in Warrants of Previously Announced Go IPO Client, SBC Medical Group Holdings*

 

*-HeartCore Signs Eighth and Ninth Go IPO Clients - Libera Gaming Operations and ICheck Co.*

**NEW YORK, NY and TOKYO, JAPAN – March 16, 2023 – HeartCore Enterprises, Inc. ("HeartCore" or the "Company")**, a leading software development company offering Customer Experience Management Platform (CXM Platform) and Digital Transformation, announced it has made compelling progress around its Go IPO consulting service offering.

As part of HeartCore's previously announced <u>fifth Go IPO win</u> with SBC Medical Group Holdings ("SBC"), SBC agreed to compensate the Company an aggregate of $900,000 in initial fees, in addition to warrants to acquire 2.7% of SBC's common stock, on a fully diluted basis. With SBC <u>recently being valued</u> at $1.2 billion, HeartCore expects to receive warrants with an approximate value of $32.4 million.

Additionally, HeartCore announced that it has entered into its eighth and ninth Go IPO agreements with Libera Gaming Operations, Inc. ("Libera") and ICheck Co., Ltd. ("ICheck"), respectively. Pursuant to the consulting agreements, HeartCore agreed to assist Libera and ICheck in their efforts to go public and list on the Nasdaq Stock Market ("Nasdaq"). Through Go IPO, the Company services clients by assisting throughout the audit and legal firm hiring process, translating requested documents into English, assisting in the preparation of documentation for internal controls required for an initial public offering or de-SPAC, providing general support services, assisting in the preparation of the S-1 or F-1 filing, and <u>more</u>.

As compensation for its services, HeartCore expects to generate from each of Libera and ICheck $600,000 in initial fees and a warrant to acquire 3% of Libera and ICheck's common stock on a fully diluted basis, respectively.

"The recent valuation of SBC Medical Group translates to a grand total of approximately $32.4 million in warrants for HeartCore," said Company CEO Sumitaka Yamamoto. "Though the initial fees we receive from clients are helpful, we believe the warrants provide exponentially greater value to our company. We are also very proud of our eighth and ninth Go IPO wins and hope to garner the benefits of our Go IPO flywheel effect as illustrated by SBC."

**About HeartCore Enterprises, Inc.**

Headquartered in Tokyo, Japan, HeartCore Enterprises is a leading software development company offering Software as a Service (SaaS) solutions to enterprise customers in Japan and worldwide. The Company also provides data analytics services that allow enterprise businesses to create tailored web experiences for their clients through best-in-class design. HeartCore's customer experience management platform (CXM Platform) includes marketing, sales, service and content management systems, as well as other tools and integrations, which enable companies to enhance the customer experience and drive engagement. HeartCore also operates a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises. Furthermore, HeartCore offers "Go IPO," a consulting service where it assists private companies with uplisting onto the Nasdaq Stock Market. Additional information about the Company's products and services is available at <u>www.heartcore.co.jp</u> and <u>https://heartcore-enterprises.com/</u>.

![](ex99-1_001.jpg)

**Forward-Looking Statements**

All statements other than statements of historical facts included in this press release are forward- looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by words such as "believe," "intend," "expect," "anticipate," "plan," "potential," "continue" or similar expressions. Such forward-looking statements include risks and uncertainties, and there are important factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. These factors, risks, and uncertainties are discussed in HeartCore's filings with the Securities and Exchange Commission. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond HeartCore's control which could, and likely will materially affect actual results, and levels of activity, performance, or achievements. Any forward-looking statement reflects HeartCore's current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. HeartCore assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The contents of any website referenced in this press release are not incorporated by reference herein.

**HeartCore Investor Relations Contact:** 

Gateway Group, Inc.

Matt Glover and John Yi

<u>HTCR@gatewayir.com</u>

(949) 574-3860